Document:

LM_EXHIBIT 10.21_3.31.2015

Exhibit 10.21

DIRECTOR’S SERVICE AGREEMENT

LEGG MASON & CO (UK) LIMITED

ISSUED April 1, 2015 FOR

Ursula Schliessler

		
	1.
	INTERPRETATION

		
	1.1
	In this Agreement the following words and expressions shall have the following meanings:

        
	
		
	“the Act”   
	Employment Rights Act 1996;

	“the Employment”
	the employment of you by the Company under this Agreement;
   

	“the Board”
	the Directors of the Company and/or the Group Company or Companies specified in Appendix A, and as modified from time to time.  This includes a Committee of the Board of the relevant Company;

	“the Company”
	Legg Mason & Co (UK) Limited as your employing entity and such Group Company or Companies as specified in Appendix A, and as modified from time to time;

	“Group Company”
	any company which is for the time being the Company’s holding company (within the meaning of Section 736 of the Companies Act 1985) or subsidiary (within such meaning) of the Company; or any subsidiary of any such holding or subsidiary company; or the Company;

	“month”
	Calendar month;

	“ the Salary”

"Working Time"

	the Salary payable to you under this Agreement

has the meaning given to it in regulation 2 of the Working Time Regulations 1998;

	“year”
	Calendar year;

	“you”
	the person in the Schedule

	 
	 

And derivative expressions shall be construed accordingly.

LND99 497693-2.077175.0010 

		
	1.2
	Words and phrases which are not defined in this Agreement but which are defined in the Act, the Companies Act 1985, the Companies Act 2006 or the Insolvency Act 1986 should be construed as having those meanings.

		
	1.3
	References to any statute or any statutory provision shall be construed as references to the statute or statutory provision as in force at the date of this Agreement and subsequently re-enacted or consolidated and shall include reference to any statute or any statutory provision of which it is a re-enactment or consolidation.

		
	1.4
	The Schedule to this Agreement is an integral part of this Agreement and references to this Agreement include reference thereto.

		
	2.
	APPOINTMENT AND TERM

		
	2.1
	The Company hereby appoints you and you agree to serve the Company upon the terms of this Agreement or in any such capacity of a like status as the Board shall from time to time reasonably require.

		
	2.2
	Your Employment began on the date set out in the Schedule and your period of continuous employment began on that date.  Your Employment shall continue until terminated by either party giving to the other the notice set out in the Schedule.

		
	2.3
	The Company may require you and you shall agree at the written request of the Board to resign without claim for compensation from office as a director or officer of the Company or as a director or officer of any Group Company or any other company or entity for which you hold office as a director or officer by virtue of your Employment by the Company, which resignation shall not affect in any way the continuing of the Employment.

		
	2.4
	You warrant and represent to the Company that you are not prevented or restricted by any agreement, arrangement, contract, understanding, Court Order or otherwise, from fully performing the duties of this Employment, or any of them, in accordance with the terms and conditions of this Agreement.  You further warrant that you are lawfully entitled to enter into this Agreement and to implement and carry out its terms and that by so doing you shall not be in breach of any obligation (contractual or otherwise) to any third party which would entitle that third party to damages or any other remedy at law and will indemnify the Company against any costs, claims, liabilities and expenses (including legal expenses on an indemnity basis) arising from any breach or alleged breach of this clause.  

		
	3.
	DUTIES

		
	3.1
	You shall during the continuance of this Agreement:

		
	3.1.1
	serve the Company to the best of your ability in the capacity set out in the Schedule or in such other capacity as the Board may from time to time determine; 

		
	3.1.2
	unless prevented by sickness or accident, devote the whole of your time attention and abilities to your duties hereunder;

		
	3.1.3
	comply with all of the Company’s and any Group Company’s rules, regulations, policies and procedures in force from time to time and comply with all the Board’s lawful and reasonable instructions;

		
	3.1.4
	exercise such powers and comply with and perform such directions and duties in relation to the businesses and affairs of the Company and any Group Company that may from time to time be vested in or given to you by the Board; 

2

		
	3.1.5
	if, and so long as the Board so directs, perform and exercise the said duties and powers on behalf of the Company and/or any Group Company and act as a director or other officer of the Company and/or any Group Company;

		
	3.1.6
	do all in your power to advance promote and develop the businesses and interests of the Company and any Group Company for which you are required to carry out duties; 

		
	3.1.7
	carry out your duties diligently, faithfully and to the highest ethical and professional standards;

		
	3.1.8
	not knowingly or recklessly do any act, or refrain from doing any act, which is likely to be to the detriment of the Company or a Group Company;

		
	3.1.9
	at all times keep the Board promptly and fully informed (in writing if so requested) of your conduct of the business or affairs of the Company and any Group Company for which you are required to perform duties and provide such explanations and assistance as  the Board may require;

		
	3.1.10
	at all times and in all respects comply with the lawful and reasonable directions of the Board and all rules or codes of conduct in force from time to time; 

		
	3.1.11
	not take any steps to encourage any employee of the Company or any Group Company to leave the employment of such company (whether immediately or in the future) with a view to being employed or engaged by, or interested or concerned in, any business, organisation or undertaking which is or will be the same as or similar to the business of the Company or any Group Company and/or which competes or will compete with the business of the Company and/or Group Company; and

		
	3.1.12
	not take any steps to encourage any actual or potential customer, client, agent or supplier of the Company and/or Group Company to:

		
	(a)
	cease or refrain from doing business with the Company and/or Group Company (whether immediately or in the future) either generally or in respect of any particular transaction; and/or

		
	(b)
	place any business (whether immediately or in the future) with any business, organisation or undertaking competing with the business of the Company or any Group Company.

		
	3.2
	Please note that the Company may require you to undertake the duties of another position, either in addition to or instead of the above duties, it being understood that you will not be required to perform duties which are not reasonably within your capabilities.  The Company reserves the right to require that you share your responsibilities with another employee of the Company or a Group Company of a similar status to you.

		
	3.3
	You may be required, in pursuance of your duties of Employment to perform services not only for the Company but also for any Group Company and, without further compensation, to accept any such office or position with the Company or a Group Company as the Company may from time to time require.  

		
	3.4
	The Company may, at its discretion, assign your Employment to any Group Company on the terms and conditions set out in this Agreement.

3

		
	4.
	WORKING HOURS

		
	4.1
	The normal business hours of the Company are 9.00am to 5.00pm Monday to Friday inclusive with a daily lunch break of one hour and shall apply to you provided that you shall work such additional hours as may be necessary for the proper discharge of your duties.  You shall not be entitled to receive any additional remuneration for any work you perform outside normal business hours.

		
	4.2
	You acknowledge that you have unmeasured Working Time for the purposes of Regulation 20 of the Working Time Regulations 1998.  

		
	4.3
	You further agree that you will comply with all and any policies or requirements of the Company as the Company may from time to time in its entire discretion decide, in relation to the recording of Working Time.

		
	5.
	REGULATORY TRAINING

		
	5.1
	Where required by the Board you shall (at the cost of the Company) undertake appropriate training (including the taking and passing of all necessary exams) to ensure that you have the relevant permissions to carry out your function as required by any relevant regulatory body (including but not limited to the Financial Conduct Authority).

		
	6.
	LOCATION & MOBILITY

		
	6.1
	Your principal place of work shall be as shown in the Schedule or such other location which may be reasonably required by the Board from time to time.  You shall also undertake any travel as may be necessary for the proper performance of those duties.

		
	6.2
	It is not currently envisaged that you will be required to travel outside the UK for periods longer than one month at a time.  In the event you are required to do so, details will be provided to you.

		
	7.
	COMPENSATION

		
	7.1
	The Company shall pay to you as salary in equal monthly instalments in arrears the amount set out in the Schedule, or as otherwise notified to you by the Company in writing from time to time, subject to statutory deductions. Your salary shall be inclusive of any directors' fees payable to you under the articles of association of the Company or any Group Company.

		
	7.2
	Your salary shall be deemed to accrue from day to day and the first monthly instalment shall be calculated from the commencement of the Employment (as set out in the Schedule) and the last monthly instalment shall be calculated down to the date of termination of the Employment.  The salary shall be payable on or about the 25th day of each calendar month. 

		
	7.3
	The Compensation Committee of the Legg Mason, Inc. Board of Directors (the “Compensation Committee”) shall review your salary annually in May and in the event of your salary being increased following this review you shall be notified of this in writing.  For the avoidance of doubt, you shall have no contractual right to any increase in salary under this clause.  Salary will not be reviewed after notice of termination of employment has been given or received.

		
	7.4
	The Company in its absolute discretion, operating under the direction of the Compensation Committee, may pay you a bonus of such amount (if any) at such times and subject to such conditions as the Compensation Committee may in its absolute discretion determine.  Bonus payments are typically made in the month of May. The payment of a bonus in any one year shall not be an indication that a bonus of any amount shall be paid in any subsequent year.  For the avoidance of doubt, you shall have no contractual right to any bonus under this clause.  You shall not be eligible to receive any bonus if this Agreement has terminated for 

4

any reason whatsoever prior to the bonus payment date nor if you have given notice or received notice of termination of the Employment prior to the bonus payment date.
		
	7.5
	Your participation in any incentive scheme operated by the Company and/or by any Group Company is subject to the terms and conditions of such schemes from time to time in force.  The Company may, at its discretion, amend or terminate such schemes, their rules, the eligibility criteria and/or incentive levels.  In such a case, neither the Company nor any Group Company will be obliged to provide an equivalent scheme or to compensate you for any loss of anticipated incentive or bonus.

		
	8.
	INSURANCES

The Company shall provide and maintain such appropriate insurances to indemnify you for your duties as a Companies Act director.
		
	9.
	PENSION

		
	9.1
	You will be eligible to participate in the Company's pension arrangements (the "Scheme") subject to the rules of the Scheme in force from time to time.  The relevant employer and employee contributions will be as separately notified to you. A contracting-out certificate is not in force for your Employment.

		
	9.2
	The Company reserves the right at any time to amend any of the rules or benefits of the Scheme and/or change scheme provider.

		
	10.
	LIFE ASSURANCE AND MEDICAL BENEFITS

		
	10.1
	During the Employment you will continue to be entitled subject to the approvals of the relevant insurer to the benefit of the Company’s Life Assurance Scheme and Permanent Health Insurance Scheme (the “PHI Scheme”) subject to the scheme rules, which may change from time to time.  Further details of this benefit can be obtained from Human Resources.

		
	10.2
	During the Employment you will continue to be entitled (subject to the approval of the relevant insurer) to the benefit of the Company’s Private Medical Insurance Scheme subject to the scheme rules, which may change from time to time.  Further details of this benefit can be obtained from Human Resources.  If any scheme provider (including any insurance company) refuses for any reason to provide any benefits to you, neither the Company nor any Group Company will be liable to provide any such benefits or any compensation in lieu of them.

		
	10.3
	Any benefits provided by the Company shall be regarded as ex gratia benefits provided at the absolute discretion of the Company and are not contractual and the Company reserves the right at any time in its absolute discretion to amend, vary, replace or terminate (without replacement) any benefits for which you may be eligible (including the rules of any such benefits which shall for the avoidance of doubt include any life assurance and/or PHI scheme in which you may from time to time participate) and/or to change or otherwise substitute any scheme and/or any provider of any such benefits.  The Company may change the scale, level or nature of the benefits package on offer (which may mean it being less beneficial to you) if it is in the best interests of the business to do so.

		
	10.4
	The Company may terminate your Employment in accordance with this Agreement for any reason despite any actual or potential entitlement you may have to any benefit including, but not limited to, permanent health insurance and/or private medical insurance.

		
	10.5
	You agree to undergo such medical examinations with a medical practitioner at the expense of the Company as may be reasonably required by the Board from time to time. You agree 

5

to give your consent to such an examination, to co-operate fully in obtaining a report from the medical practitioner and to authorise full disclosure of the report to the Company.
		
	11.
	HOLIDAYS

		
	11.1
	You shall be entitled to the number of days holidays set out in the Schedule on full pay in each holiday year in addition to Bank and Public Holidays. Such holiday is to be taken at such reasonable time or times as the Board shall approve.  Regulations 15(1) to 15(4) of The Working Time Regulations 1998 (“Dates on which leave is taken”) shall not apply to the Employment.

		
	11.2
	The Company’s holiday year runs from 1 January to 31 December each year.  Upon termination of the Employment you shall either be entitled to salary in lieu of any outstanding pro rata holiday entitlement or be required to pay to the Company any salary received in respect of holiday taken in excess of your pro rata holiday entitlement such salary shall be calculated on the basis of 1/260 of the annual salary payable to you for each day of outstanding or excess holiday entitlement as appropriate.  The Company may require you to take any holiday entitlement to which you may be entitled during any period of notice or any period that you are directed to perform no duties and/or are directed not to enter all or any premises of the Company or Group Company in accordance with Clause 18.  

		
	11.3
	You shall not be entitled to payment in lieu of your holiday entitlement except on termination of the Employment. Holiday entitlement should usually be taken in the holiday year in which it occurs. Any holiday entitlement remaining unused at the end of the holiday year may be carried over with the prior written consent of the Board in accordance with and subject to the procedures laid out in the Employee Handbook.  Failure to take holiday entitlement in the appropriate holiday year (other than permitted carry forward) will lead to forfeiture of that accrued but untaken holiday without any right to be paid in lieu of it.  

		
	11.4
	You are subject to any other provisions regarding holiday entitlement as are contained in the Company’s holiday entitlement policies from time to time in force.

6

		
	12.
	SICKNESS OR ACCIDENT

		
	12.1
	During any period in which you may be incapacitated from performing your duties hereunder due to sickness or accident the Company will, subject to your compliance with the Company's notification procedures (set out in Clause 12.3 below), pay to you during the first six consecutive months of such incapacity a sickness allowance based your basic salary.  For statutory sick pay (“SSP”) purposes your qualifying days shall be Monday to Friday inclusive.  The Company may at its absolute discretion pay you a further allowance after the end of the six month period.  You shall have no contractual right to any payments (over and above statutory sick pay) and any payments made by the Company shall be provided at the Company's absolute discretion.  Any sick pay you may receive will be subject to the usual statutory deductions.  Where Company sick pay and SSP fall to be paid for the same day(s) of absence, you will receive the higher of the two sums only.  During any such period of absence, the Company shall be entitled at any time to appoint another employee to perform your duties. 

		
	12.2
	If you receive any sums by way of compensation for loss of earnings under this Agreement from a third party in respect of the period for which the Company has made payments for sickness allowance to you, such payment shall be treated as being made by way of loan and shall be recoverable by the Company.  You shall keep the Company informed of the commencement, progress and outcome of any such claim.

		
	12.3
	If you are absent from work due to illness or injury you must notify Human Resources as soon as possible on the first working day of incapacity.  You shall complete any self-certification forms which are required by the Company immediately upon your return to work and if your incapacity continues for more than seven consecutive days (whether working days or not) you shall produce medical certificates to cover the duration of your absence from work. Further details of the procedure to follow can be found in the Employment Policies and Procedures Manual.

		
	12.4
	In the event that you are, by reason of your sickness or other medical incapacity, absent from work and/or unable to perform all of your duties under this Agreement, the Company will have the right, at any time after you have been absent for 120 days, either consecutively or in aggregate, in any 12 month period, to terminate your Employment on notice.  In the event that you are not in receipt of salary or Company sick pay at the time you are issued with notice of termination in these circumstances, you will not be entitled to any salary or Company sick pay during or in respect of your notice period.

		
	13.
	CONFIDENTIALITY

		
	13.1
	You acknowledge that during the period of the Employment you shall in the performance of your duties become aware of trade secrets and other Confidential Information relating to the Company, the Group Company, their businesses and its or their clients or customers and their businesses.

		
	13.2
	Without prejudice to your general duties at common law in relation to trade secrets and other Confidential Information you shall not at any time whether during the continuance of the Employment or at any time after its termination divulge to any third party whatsoever or use for your own or another’s advantage any of the trade secrets accounts financial or trading information or other Confidential Information which you may receive or obtain in relation to the business finances dealings or affairs of the Company or any Group Company including any information regarding the products, processes, formulae, research projects or other technical data or the customers suppliers or agents for the Company or any Group Company or any Intellectual Property as defined in Clause 14 below except insofar as it may be necessary for you to do any of the foregoing in the performance of your duties hereunder or unless you are ordered to do so by a court of competent jurisdiction or unless it is approved in writing by the Board.

7

		
	13.3
	For the avoidance of doubt, but without limitation, “Confidential Information” includes but is not limited to in relation to the Company’s or any Group Company’s financial products their cost, profitability, margins, marketing initiatives, technical specifications, degree of take-up by the intended client base, forecasts and tax treatments or concessions particular to that product and all information which relates to the business, finances, transactions, affairs, products, services, processes, equipment or activities of the Company and any other Group Company which is designated by the Company and any other Group Company as confidential and all information relating to such matters which come to your knowledge in the course of the Employment and which, by reason of its character or the manner of its coming to your knowledge, is evidently confidential.

		
	13.4
	The provisions of this Clause shall cease to apply to information or knowledge which comes into the public domain otherwise than by reason of your default.  In particular, the restrictions in this Clause 13 will not apply to Confidential Information which:

		
	13.4.1
	is already in the public domain;

		
	13.4.2
	you are entitled to disclose under the Public Interest Disclosure Act 1998;

		
	13.4.3
	you are required to disclosure by law; and/or

		
	13.4.4
	you are expressly authorised in writing by the Company to use or disclose.

		
	13.5
	You may not at any time during your Employment make any copy, record, notes or memoranda (whether or not recorded in writing or electronically) relating to any Confidential Information, otherwise than pursuant to your terms and conditions of Employment.

		
	14.
	INTELLECTUAL PROPERTY

		
	14.1
	For the purposes of this Clause and Clause 13 above, the following term shall have the following meaning:

“Intellectual Property” means all patents, trademarks and service marks, registered designs, design rights and copyright (including without limitation rental and lending rights), rights in performances, moral rights, rights in databases and other protectable lists of information, rights in confidential information, trade secrets, inventions and know-how, trade and business names, domain names, getups and logos, development, plans, designs, formulae, specifications, programs and other similar industrial or commercial rights or other matter or work whatsoever (including all extensions, revivals and renewals, where relevant) whether registered or unregistered and the goodwill attaching to any of them and applications for any of them and any rights or forms of protection of a similar nature and having equivalent or similar effect to any of them which may subsist anywhere in the world.
		
	14.2
	You agree that any Intellectual Property (including all records, documents, papers and copies or summaries thereof) made, discovered or created (wholly or partly) by you:

		
	14.2.1
	in the course of your normal duties; or

		
	14.2.2
	in the course of duties falling outside your normal duties but which are specifically assigned to you by the Board; or

		
	14.2.3
	in the course of your duties and at the time of making, creating or discovering the Intellectual Property, because of the nature of your duties and the particular responsibilities arising from the nature of your duties you have a special obligation to further the interests of the Company; or

		
	14.2.4
	using information obtained during the course of your Employment; or 

8

		
	14.2.5
	which is or may be relevant to the Company’s or a Group Company’s existing or future business, 

(collectively “Executive Rights”) shall belong to and be the absolute property of the Company.
		
	14.3
	You will immediately disclose to the Company full details of all such Intellectual Property and /or Executive Rights (including all materials embodying or relating to the Intellectual Property or Executive Rights regardless of format) and (both during your Employment and after its termination) agree that you will keep confidential any and all information in any way relating to the Intellectual Property and/or the Executive Rights.  You further agree that (both during your Employment and after its termination), you will at the Company’s expense execute all documents and take all actions reasonably required by the Company to protect such Intellectual Property and to confirm ownership of and all rights in such Intellectual Property in the Company or its nominee absolutely and as sole legal and beneficial owner.

		
	14.4
	You hereby irrevocably and unconditionally waive as against the Company or subsequent assignee of the Company all and any rights (including any moral rights) you may have now or in the future in any copyright work as is referred to above pursuant to Chapter IV of Part I of the Copyright, Designs and Patents Act 1988 and all similar rights in other jurisdictions that vest in you (whether before, on or after the date hereof) in connection with your authorship of any copyright works in the course of your Employment, wherever in the world enforceable, including without limitation the right to be identified as the author or any such works and the right not to have any such works subjected to derogatory treatment.

		
	14.5
	The Company and you both acknowledge and accept the provisions of Sections 39 to 42 of the Patents Act 1977 ("the Act") relating to the ownership of employees’ inventions and the compensation of employees for certain inventions.

		
	14.6
	You agree that, by virtue of the nature of your duties and the responsibility arising from them, you have and shall have at all times a special obligation to further the interests of the Company within the meaning of Section 39(1)(b) of the Act.

		
	14.7
	You agree, at the request and cost of the Company (and notwithstanding the termination of your employment) to immediately license or assign (as requested by the Company) all aspects of the Intellectual Property and/or Executive Rights to the Company and to deliver to the Company all documents and other materials relating to the Intellectual Property and/or Executive Rights.  The Company shall pay you compensation for the license or assignment as the Company shall determine in its absolute discretion, subject to Section 40 of the Act.

		
	14.8
	You also agree, at the request and cost of the Company (and notwithstanding the termination of your employment) to sign and execute all such documents and do all such acts as the Company may reasonably require:

9

		
	14.8.1
	to apply for and obtain in the sole name of the Company alone (unless the Company otherwise directs) patent, registered design, or other protection of any nature whatsoever in respect of the Intellectual Property and/or Executive Rights in any country throughout the world and, when so obtained or vested, to renew and maintain the same;

		
	14.8.2
	to resist any objection or opposition to obtaining, and any petitions or applications for revocation of, any such patent, registered design or other protection;

		
	14.8.3
	to bring any proceedings for infringement of any such patent, registered design or other protection, the Company having sole control of all aspects of such proceedings and/or disputes relating to the same;  and

		
	14.8.4
	otherwise to give effect to the assignments, waivers and licences contemplated under this clause.

		
	14.9
	The Company shall decide, in its sole discretion, whether to apply for patent, registered design or other protection in respect of the Intellectual Property and/or Executive Rights.

		
	15.
	REGULATORY BODIES/STAFF DEALING RULES

		
	15.1
	You undertake to ensure that you abide by the rules of any relevant regulatory body (including but not limited to the Financial Conduct Authority).

		
	15.2
	A breach of regulatory rules would be a serious matter, which may in certain circumstances result in summary dismissal.

		
	15.3
	In abiding by the relevant rules, you agree to comply and co-operate fully with all instruction, directions, requirement or request properly made or imposed by the Board on behalf of the regulatory bodies.

		
	15.4
	You confirm that you have read and signed a copy of the Company's Staff Dealing Rules which form part of the terms and conditions of the Employment.

10

		
	16.
	TERMINATION

		
	16.1
	The Company shall at all times be entitled to terminate this Agreement by giving you such statutory notice as required by UK law.

		
	16.2
	The Company may summarily terminate the Employment immediately without notice in any of the following circumstances (which are by way of illustration only and are not intended to be comprehensive.  Further grounds for summary termination can be found in the Employee Handbook): 

		
	16.2.1
	if you shall be guilty of any material dishonesty, gross misconduct or wilful neglect of duty or shall commit any continued breach of the terms of this Agreement after warning or shall be guilty of conduct likely to bring you, the Company or any Group Company into disrepute;

		
	16.2.2
	if you are convicted of an indictable offence;

		
	16.2.3
	if you shall become bankrupt or make any arrangement or composition with your creditors;

		
	16.2.4
	if you shall be guilty of any form of personal investment or hedging strategies, or liability-related contracts of insurance to undermine risk alignment efforts embedded in your compensation arrangements;

		
	16.2.5
	if you are, or may be suffering from mental disorder and either:

		
	(i)
	you are admitted to hospital in pursuance of an application for admission for treatment under the Mental Health Act 1983 or, in Scotland, an application for admission under the Mental Health (Scotland) Act 1960, or

		
	(ii)
	an order is made by a court having jurisdiction (whether in the United Kingdom or elsewhere) in matters concerning mental disorder for your detention or for the appointment of a receiver, curator bonis or other person to exercise powers with respect to your property or affairs;

11

		
	16.2.6
	if you shall become of unsound mind;

		
	16.2.7
	if you are convicted of an offence under any present or future statutory enactment or regulation relating to insider dealing;

		
	16.2.8
	if you shall be guilty of any breach of confidentiality i.e. misuse or disclosure of information concerning the business of the Company or any Group Company or that of the clients of the Company or any Group Company;

		
	16.2.9
	if you shall breach clause 15.1 or 15.3 or fail to comply with the authorisation given to you to conduct investment business or conduct investment business without such authorisation;

		
	16.2.10
	if you shall be guilty of any form of prohibited harassment or discrimination;

		
	16.2.11
	if you shall be guilty of making any unauthorised gain out of any transaction conducted in the business of the Company or any Group Company;

		
	16.2.12
	if you refuse or neglect to undertake any required training at the Company’s discretion;

		
	16.2.13
	if you voluntarily resign as a director of the Company or any Group Company;

		
	16.2.14
	if you fail any relevant exam required by any relevant regulatory body or your registration and/or approval by any relevant regulatory body is withdrawn;

		
	16.2.15
	if you are or become prohibited by law or the articles of association of the Company or any regulatory body applicable to the Company from being a director.

		
	16.3
	Upon the termination of your Employment for whatsoever reason or upon your exclusion in accordance with Clause 18 or upon either you or the Company serving notice on the other of termination of your Employment, you agree that you will (without prejudice to any other rights accruing to either party hereto) immediately resign from office as a Director of all Group Companies and from any offices held by you in any Group Company and from offices held in any other company or entity held by virtue of your Employment by the Company.  In the event that you fail to comply with your obligations under this Clause 16.3 within 5 working days of any of these events, by signature of this document as a Deed, you hereby irrevocably appoint the Company to act as your attorney with authority in your name and on your behalf to sign or execute any and all agreements, instruments, deeds or other papers and to do all such things in your name as may be reasonably necessary or desirable to implement such obligations.

		
	16.4
	The proper exercise by the Company of its rights of termination under Clause 16.2 shall be without prejudice to any other rights or remedies which the Company or any Group Company may have or be entitled to exercise against you.

		
	16.5
	You shall not at any time during your Employment or during any period when you are required to cease the performance of your duties under Clause 16 or after the termination of your Employment make any public statements in relation to the Company or any Group Company or any of their officers or employees.  You shall not after the termination of your Employment represent yourself as being employed by or connected with the Company or any Group Company.  For the avoidance of doubt, you may not at any time make or communicate any statement (whether verbally or in writing) with any representative of the press, television, radio or other media.

		
	16.6
	Upon termination of your Employment, you shall:

12

		
	16.6.5
	return to the Company, all Company property which is in your possession or under your control and without you or anyone on your behalf keeping copies or downloading data or otherwise replicating the returned property; and

		
	16.6.6
	immediately repay all outstanding debts or loans due to the Company or any Group Company.

		
	17.
	NO OTHER INTERESTS

		
	17.1
	You undertake that you shall not at any time during the continuance of the Employment without the prior consent of the Chief Executive Officer of Legg Mason, Inc. become a Director of any company (other than the Company or any Group Company) except in the course of your duties hereunder or be engaged concerned or interested directly or indirectly in any other business trade or occupations.

		
	17.2
	Nothing in this Agreement shall prevent you from: 

		
	17.2.1
	being or becoming a Director of another company or being engaged concerned or interested in any other business trade or occupation with the consent of the Chief Executive Officer of Legg Mason, Inc. ; or

		
	17.2.2
	holding or being beneficially interested in not more than five percent of any class of securities in any company if such class of securities is quoted or dealt in on a Recognised Investment Exchange (as defined in Section 285 of the Financial Services and Markets Act 2000).

		
	18.
	PAID LEAVE OF ABSENCE

The Company reserves the right to require you not to attend work or perform any services (or perform different services) on its behalf at any time during the Employment for a period of up to 12 weeks.  During any such period, you will remain an employee and consequently will remain governed by all the provisions of this Agreement including, without limitation, the confidentiality and exclusive service provisions of this Agreement.  During any such period where the Company exercises this right, you will continue to be entitled to full salary and benefits (excluding bonus) but shall not be entitled to access to any premises of the Company or any Group Company nor to contact any employees, officers, customers, clients, agents or suppliers of the Company or any Group Company without the prior consent of the Board. 
		
	19.
	POST-TERMINATION RESTRICTIONS

		
	19.1
	For the purpose of this Clause 19:

"the Business" means any business carried on by the Company or any Group Company at the date of termination of your Employment and with which you have been concerned to a material extent in the 12 months immediately preceding such termination;
references to "Group Companies" shall only be references to Group Companies in respect of which you have carried out material duties in the period of 12 months prior to the date of termination of your Employment;
"Restricted Person" shall mean any person who or which has at any time during the period of 12 months immediately preceding the date of termination of your Employment done business with the Company or any Group Company as customer or client or distributor or consultant and with whom or which you shall have had personal dealings, contact with or responsibility for during the course of your Employment;

13

"Key Employee" shall mean any person who at the date of termination of your Employment is employed or engaged by the Company or any Group Company with whom you have had material contact during the course of your Employment and (a) is employed or engaged in either a management capacity, at Grade 2 or above or in a sales or marketing capacity and/or (b) is in the possession of Confidential Information belonging to the Company and/or (c) is directly managed by or reports to you.
		
	19.2
	You acknowledge that during the course of your Employment with the Company that you will receive and have access to Confidential Information of the Company and the Group Companies and that you will have influence over and connection with customers clients and employees of the Company and the Group Companies with which you come in contact during your Employment and accordingly you are willing to enter into the covenants described in this Clause in order to provide the Company and the Group Companies with reasonable protection for their interests.

		
	19.3
	You covenant with the Company that you will not in connection with the carrying on of any business in competition with the Business for the period of 12 months after the termination of your Employment without the prior written consent of the Company either alone or jointly with or on behalf of any person directly or indirectly:

		
	19.3.7
	do business with a Restricted Person;

		
	19.3.8
	canvass solicit or approach or cause to be canvassed or solicited or approached for orders in respect of any services provided and/or goods sold by the Company or any Group Company any Restricted Person; and

		
	19.3.9
	solicit or entice away or endeavour to solicit or entice away from the Company or any Group Company any Key Employee (in each case whether or not such person would commit a breach of contract by so doing).

		
	19.4
	You covenant with the Company that you will not for the period of 12 months after the termination of your Employment either alone or jointly with any other person directly or indirectly induce or attempt to induce any supplier of the Company or any Group Company with whom you have had personal dealings, contact with or responsibility for during the course of your Employment to cease to supply or to restrict or vary the terms of supply to the Company or any Group Company or otherwise interfere with the relationship between such a supplier and the Company or any Group Company.

		
	19.5
	The periods during which restrictions in this Clause are expressed to operate shall each be reduced by such period as you shall have complied immediately prior to the termination of the Employment with the direction to perform no duties and/or not to enter all or any premises of the Company or any Group Company in accordance with Clause 18.

		
	19.6
	You agree that you will at the cost of the Company enter into a direct agreement or undertaking with any Group Company whereby you will accept restrictions and provisions corresponding to the restrictions and provisions in this clause (or such of them as may be appropriate in the circumstances) in relation to such activities and such area and for such a period not exceeding 6 months as such Group Company may reasonably require for the protection of its legitimate business interests..

		
	19.7
	The covenants contained in this Clause 19 are intended to be separate and severable and enforceable as such.  If at any time a court of competent jurisdiction decides that any part of any restriction goes beyond what is fair and reasonable in all the circumstances for the protection of the Company but that the restriction would be fair and reasonable if any part of parts of the wording were deleted the restriction shall apply with such words deleted.

		
	19.8
	You acknowledge and agree that you shall be obliged to draw the provisions of this Clause 19 to the attention of any third party who may at any time before or after the termination of 

14

your Employment under this Agreement offer to employ or engage you in any capacity and for whom or with whom you intend to work during the period of 6 months following the termination of the Employment.
		
	20.
	DISCIPLINARY, DISMISSAL AND GRIEVANCE PROCEDURES

		
	20.1
	You can obtain details of the Company's disciplinary, dismissal and grievance procedures from the Employment Policies and Procedures Manual.  The Company's disciplinary, dismissal and grievance procedures are intended to be a guide to best practice and are to be operated at the Company's discretion.  The procedures shall not form part of your terms and conditions of your Employment. 

		
	20.2
	In order to investigate a complaint against you, the Company reserves the right to suspend you on full pay and to exclude you from any premises of the Company and any Group Company as long as it deems necessary to carry out a proper investigation and to hold any appropriate disciplinary hearings.  

		
	21.
	DOCUMENTS AND OTHER PROPERTY

All documents, records, correspondence, price lists, accounts, statistics, equipment, computer discs, databases, keys, security passes or other property relating to the business or affairs of the Company or any Group Company and kept in the possession or under the control of you and all copies thereof or extracts there from made by or on behalf of you shall be and remain the property of the Company and shall be delivered up to the Company immediately on termination of the Employment.
		
	22.
	DEDUCTIONS

		
	22.1
	For the purposes of the Act and otherwise, you consent to the deduction, during your Employment and on its termination (howsoever arising), from your salary of any sums owing by you to the Company or any Group Company at any time and you also agree to make any payment to the Company of any sums owing by you to the Company or any Group Company upon demand by the Company or any Group Company at any time.  This Clause is without prejudice to the rights of the Company to recover any sums or balance of sums owing by you to the Company or any Group Company by legal proceedings.

		
	22.2
	The sums the Company may recover under Clause 22.1 above may include, but are not limited to, any outstanding loans, training costs, relocation expenses, advances, the cost of repairing any damage or loss to the Company’s or any Group Company’s property caused by you, excess holiday pay and any other monies owed by you to the Company or any Group Company.

		
	23.
	EXPENSES

		
	23.1
	The Company will reimburse you for all reasonable business expenses properly and reasonably incurred by you in the proper performance of your duties of Employment (against receipts or other satisfactory evidence) subject to the Company’s expenses policy from time to time in force.

		
	24.
	ENTIRE AGREEMENT

This Agreement (including its Schedule) and any other relevant contractual documents referred to herein constitutes the entire and only legally binding Agreement relating to your Employment by the Company or any Group Company and is in substitution for and shall supersede all former and existing agreements or arrangements for the employment of you by the Company or any Group Company all of which shall be deemed to have been terminated by mutual consent.

15

		
	25.
	EMPLOYMENT RIGHTS ACT 1996

This Agreement shall also be subject to the terms of the Schedule hereto which together with this Agreement contains the written statement of the particulars of your Employment hereunder required to be given under Section 1 of the Employment Rights Act 1996.
		
	26.
	NOTICE

Any notice required to be given hereunder shall be deemed duly served if delivered by hand or sent by special or recorded delivery post to the Company at its registered office for the time being or to you at your last known address and shall be deemed to be served at the time when the same is delivered to such address or if served by post forty-eight hours after the time of posting.

16

		
	27.
	ADDITIONAL RULES/TERMS/EMPLOYEE HANDBOOK

Any additional rules referred to in this Agreement shall be made available by the Company to you for inspection in the Company’s Human Resources Department.  As a condition of your Employment, you will be required to comply at all times with the terms of any Employee Handbook and other staff policies and procedures applicable from time to time.  The Employee Handbook and other policies and procedures may be amended from time to time and do not form part of this Agreement and do not have contractual force except where expressly stated.  Where the contents of any Employee Handbook (as amended from time to time), separate policies and this Agreement conflict, this Agreement will take precedence.
		
	28.
	GENERAL

		
	28.1
	The various provisions, sub-provisions and other identifiable parts of this Agreement (including any schedules) are severable and if any provision of this Agreement shall be or are deemed to be void or unenforceable for any reason by a Court of any competent jurisdiction, this shall effect neither the validity of that provision within any other jurisdiction nor any of the remaining provisions of this Agreement.

		
	28.2
	This Agreement and the rights and obligations of the parties hereto shall be governed by and construed in accordance with the laws of England and Wales.

		
	28.3
	In the event of any claim, dispute or difference arising out of or in connection with this Agreement the parties hereto irrevocably agree and submit to the exclusive jurisdiction of the Courts of England.

		
	28.4
	The benefit of each of your agreements and obligations under this Agreement may be assigned to and enforced by all successors and assignees for the time being of the Company and its Group Companies and such agreements and obligations will operate and remain binding despite the termination of this Agreement. The Company may require you to enter into a Deed directly with any Group Company under which you give direct undertakings to any Group Company in the terms set out in this Agreement.

		
	28.5
	Any reference in this Agreement to an Act of Parliament will be deemed to include any statutory modification or re-enactment thereof.

		
	28.6
	Any reference in this Agreement to the Company shall be deemed to include a reference to Group Company. 

		
	28.7
	You agree that you will have no claim against the Company or any Group Company if your employment is terminated by reason of the liquidation of the Company or for the purposes of amalgamation or reconstruction or otherwise as long as you are offered re-employment with any concern or undertaking resulting from such amalgamation or reconstruction on terms and conditions which, taken as a whole, are not substantially less favourable than the terms of this Agreement.

		
	28.8
	The parties acknowledge that, during your employment, you may be granted rights upon the terms and subject to the condition of the rules from time to time of the Company’s share scheme (if any) or any other profit sharing, share incentive, share option, bonus or phantom option scheme operated by the Company or any Group Company.  If, on termination of your employment, for whatever reason, whether lawfully or in breach of contract, you lose any of the rights or benefits under such scheme (including rights or benefits which you would not have lost had your employment not been terminated) you will not be entitled, by way of compensation for unlawful termination of employment, loss of employment or office or otherwise, to any compensation for loss of any rights or loss of profits under any such scheme.

17

		
	29.
	ELIGIBILITY TO WORK IN THE UK

You must continue to comply with all conditions in respect of any work permit or other documentation entitling you to work in the UK.  Failure to do so will result in immediate termination of the Employment.  You agree to immediately inform the Company, in writing, in the event that, for whatever reason, you become unable to perform your duties under this Agreement.  To avoid doubt, this obligation shall include, but shall not be limited to, an obligation to inform the Company immediately if you lose, or are likely to lose, the right to work in the UK and/or to perform the duties required by this Agreement.
		
	30.
	PERSONAL DATA

		
	30.1
	You must at all times during your Employment act in accordance with any policy or instruction introduced by the Company to ensure compliance with the Data Protection Act 1998 or any other applicable data protection legislation.

		
	30.2
	You explicitly consent to: 

		
	30.2.1
	the Company processing any Personal Data relating to you;

		
	30.2.2
	the Company processing any sensitive Personal Data relating to you including without limit, any self certification forms or medical certificates supplied to the Company to explain your absence by reason or sickness or injury, any records of sickness absence, any medical reports or health assessments, any details of your trade union memberships or any information relating to any criminal convictions or any criminal charges secured or brought against you; and

		
	30.2.3
	the Company collecting and disclosing your Personal Data (including sensitive Personal Data) from time to time and with third parties;

where such action is necessary or reasonably required by the Company for performance of this Agreement, the conduct of the Company's business or the proper administration of the employment relationship (both during and after your Employment) or where such action is required by law.
		
	30.3
	In this clause "Personal Data", "Processing" and "sensitive Personal Data" shall have the meaning set out in Sections 1 and 2 of the Data Protection Act 1998.

		
	30.4
	A copy of the Company’s Employee Data Protection Policy can be found as part of the Company’s Employee Policies and Procedures, as amended from time to time.

		
	31.
	THIRD PARTY RIGHTS

		
	31.1
	It is agreed that save for a Group Company, no terms of the Agreement shall be enforceable by a Third Party in his own right by virtue of Section 1(1) of the Contracts (Rights of Third Parties) Act 1999.

		
	31.2
	For the purposes of this clause a “Third Party” means any person who is not named as a party to this Agreement.

18

APPENDIX A

Ursula Schliessler will be proposed as a Companies Act Director on the Board of the following Companies:

	
			
	DIRECTORSHIPS
	 
	 

	Company
	Date of appointment
	Date of retirement

	Legg Mason Investments (Europe) Limited
	28 April 2010
	N/A

	Legg Mason Investment Funds Limited
	28 April 2010
	N/A

	Legg Mason Investments (Taiwan) Limited
	31 January 2013
	N/A

	Legg Mason Asset Management (Japan) Co. Ltd
	15 February 2013
	N/A

	Legg Mason Asset Management Hong Kong Limited
	30 April 2013
	N/A

	Legg Mason Asset Management Australia Limited
	21 June 2013
	N/A

	Legg Mason Asset Management Singapore Pte. Limited
	18 September 2013
	N/A

19

The Schedule

Written Statement of Particulars of Employment as at 1 April 2015

	
			
	1.
	Employer
	Legg Mason & Co (UK) Limited

	 
	Registered Address
	201 Bishopsgate, London EC2M 3HB

	 
	 
	 

	2
	Employee
	Ursula Schliessler

	 
	 
	 

	3.
	Date of Commencement of Continuous Period of Employment by the Company
	April 6, 2010

	 
	 
	 

	4.
	Functional & Corporate Title/ 
Reporting to
	Chief Administrative Officer reporting to the Chief Executive Officer

	 
	 
	 

	5.
	Hours of work
	Normal office hours shall be from 9.00am to 5.00pm Monday to Friday inclusive with a daily lunch break of one hour.  You shall also be required to work such additional hours as may be reasonable for the proper performance of your duties.  You shall not be entitled to any additional remuneration for work performed outside normal office hours.

	 
	 
	 

	6.
	Your Principal Place of Work
	201 Bishopsgate, London EC2M 3AB

	 
	 
	 

	7.
	Salary
	£225,000 less statutory deductions
Paid in 12 monthly payments

	 
	 
	 

	8.
	Current Year Entitlement
	30 days

	 
	 
	 

	9.
	Annual Holiday Entitlement
	30 days

	 
	 
	 

	10.

	Collective Agreements
	There are no Collective Agreements in force in respect of your Employment.

	 
	 
	 

	11.
	Notice Period
	3 months written notice from the Employee.

20

EXECUTED as a deed

	
			
	Executed as a Deed by
	)
	 

	Legg Mason & Co (UK) Limited
	)
	 

	 
	)
	..............................

	 
	)
	Brian Eakes

	 
	)
	Director

	 
	)
	on...........................

	 
	 
	 

	 
	 
	 

	 
	 
	 

	 
	 
	 

	 
	 
	 

	Executed as a Deed by
	)
	 

	Ursula Schliessler
	)
	 

	in the presence of:
	)
	..............................

	 
	)
	Ursula Schliessler

	 
	)
	on...........................

	 
	)
	 

Signature of witness:
...............................................            
Name of witness:
...............................................            
Address of witness:
...............................................
...............................................
...............................................
Occupation of witness:
...............................................            

21EX-4.1

 EXHIBIT 4.1 

 
  

 
 INOVIO PHARMACEUTICALS, INC.

 SENIOR DEBT SECURITIES 
  

 
 INDENTURE

 Dated as of ____________________ 
  

 

___________________________________ 
 Trustee 
  

 
  

 
  

 TABLE OF CONTENTS 

 

					
	 	  	PAGE	 
	 ARTICLE 1 DEFINITIONS
	  	 	1	  
		
	 Section 1.01 Definitions of Terms
	  	 	1	  
		
	 ARTICLE 2 ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION AND EXCHANGE OF SECURITIES
	  	 	5	  
		
	 Section 2.01 Designation and Terms of Securities
	  	 	5	  
		
	 Section 2.02 Form of Securities and Trustee’s Certificate
	  	 	7	  
		
	 Section 2.03 Denominations: Provisions for Payment
	  	 	7	  
		
	 Section 2.04 Execution and Authentications
	  	 	9	  
		
	 Section 2.05 Registration of Transfer and Exchange
	  	 	9	  
		
	 Section 2.06 Temporary Securities
	  	 	10	  
		
	 Section 2.07 Mutilated, Destroyed, Lost or Stolen Securities
	  	 	11	  
		
	 Section 2.08 Cancellation
	  	 	12	  
		
	 Section 2.09 Benefits of Indenture
	  	 	12	  
		
	 Section 2.10 Authenticating Agent
	  	 	12	  
		
	 Section 2.11 Global Securities
	  	 	13	  
		
	 ARTICLE 3 REDEMPTION OF SECURITIES AND SINKING FUND PROVISIONS
	  	 	14	  
		
	 Section 3.01 Redemption
	  	 	14	  
		
	 Section 3.02 Notice of Redemption
	  	 	14	  
		
	 Section 3.03 Payment Upon Redemption
	  	 	15	  
		
	 Section 3.04 Sinking Fund
	  	 	16	  
		
	 Section 3.05 Satisfaction of Sinking Fund Payments with Securities
	  	 	16	  
		
	 Section 3.06 Redemption of Securities for Sinking Fund
	  	 	16	  
		
	 ARTICLE 4 COVENANTS
	  	 	17	  
		
	 Section 4.01 Payment of Principal, Premium and Interest
	  	 	17	  
		
	 Section 4.02 Maintenance of Office or Agency
	  	 	17	  
		
	 Section 4.03 Paying Agents
	  	 	17	  
		
	 Section 4.04 Appointment to Fill Vacancy in Office of Trustee
	  	 	19	  
		
	 Section 4.05 Compliance with Consolidation Provisions
	  	 	19	  

  
 -i-

 TABLE OF CONTENTS 

(CONTINUED) 
  

					
	 	  	PAGE	 
	 ARTICLE 5 SECURITYHOLDERS’ LISTS AND REPORTS BY THE COMPANY AND THE TRUSTEE
	  	 	19	  
		
	 Section 5.01 Company to Furnish Trustee Names and Addresses of Securityholders
	  	 	19	  
		
	 Section 5.02 Preservation Of Information; Communications With Securityholders
	  	 	19	  
		
	 Section 5.03 Reports by the Company
	  	 	20	  
		
	 Section 5.04 Reports by the Trustee
	  	 	20	  
		
	 ARTICLE 6 REMEDIES OF THE TRUSTEE AND SECURITYHOLDERS ON EVENT OF DEFAULT
	  	 	20	  
		
	 Section 6.01 Events of Default
	  	 	20	  
		
	 Section 6.02 Collection of Indebtedness and Suits for Enforcement by Trustee
	  	 	22	  
		
	 Section 6.03 Application of Moneys Collected
	  	 	23	  
		
	 Section 6.04 Limitation on Suits
	  	 	24	  
		
	 Section 6.05 Rights and Remedies Cumulative; Delay or Omission Not Waiver
	  	 	24	  
		
	 Section 6.06 Control by Securityholders
	  	 	25	  
		
	 Section 6.07 Undertaking to Pay Costs
	  	 	25	  
		
	 ARTICLE 7 CONCERNING THE TRUSTEE
	  	 	26	  
		
	 Section 7.01 Certain Duties and Responsibilities of Trustee
	  	 	26	  
		
	 Section 7.02 Certain Rights of Trustee
	  	 	27	  
		
	 Section 7.03 Trustee Not Responsible for Recitals or Issuance or Securities
	  	 	28	  
		
	 Section 7.04 May Hold Securities
	  	 	29	  
		
	 Section 7.05 Moneys Held in Trust
	  	 	29	  
		
	 Section 7.06 Compensation and Reimbursement
	  	 	29	  
		
	 Section 7.07 Reliance on Officers’ Certificate
	  	 	29	  
		
	 Section 7.08 Disqualification; Conflicting Interests
	  	 	30	  
		
	 Section 7.09 Corporate Trustee Required; Eligibility
	  	 	30	  
		
	 Section 7.10 Resignation and Removal; Appointment of Successor
	  	 	30	  
		
	 Section 7.11 Acceptance of Appointment By Successor
	  	 	31	  
		
	 Section 7.12 Merger, Conversion, Consolidation or Succession to Business
	  	 	33	  
		
	 Section 7.13 Preferential Collection of Claims Against the Company
	  	 	33	  

  
 -ii-

 TABLE OF CONTENTS 

(CONTINUED) 
  

					
	 	  	PAGE	 
	 Section 7.14 Notice of Default
	  	 	33	  
		
	 ARTICLE 8 CONCERNING THE SECURITYHOLDERS
	  	 	33	  
		
	 Section 8.01 Evidence of Action by Securityholders
	  	 	33	  
		
	 Section 8.02 Proof of Execution by Securityholders
	  	 	34	  
		
	 Section 8.03 Who May be Deemed Owners
	  	 	34	  
		
	 Section 8.04 Certain Securities Owned by Company Disregarded
	  	 	34	  
		
	 Section 8.05 Actions Binding on Future Securityholders
	  	 	35	  
		
	 ARTICLE 9 SUPPLEMENTAL INDENTURES
	  	 	35	  
		
	 Section 9.01 Supplemental Indentures Without the Consent of Securityholders
	  	 	35	  
		
	 Section 9.02 Supplemental Indentures With Consent of Securityholders
	  	 	36	  
		
	 Section 9.03 Effect of Supplemental Indentures
	  	 	37	  
		
	 Section 9.04 Securities Affected by Supplemental Indentures
	  	 	37	  
		
	 Section 9.05 Execution of Supplemental Indentures
	  	 	37	  
		
	 ARTICLE 10 SUCCESSOR ENTITY
	  	 	38	  
		
	 Section 10.01 Company May Consolidate, Etc.
	  	 	38	  
		
	 Section 10.02 Successor Entity Substituted
	  	 	39	  
		
	 Section 10.03 Evidence of Consolidation, Etc. to Trustee
	  	 	39	  
		
	 ARTICLE 11 SATISFACTION AND DISCHARGE
	  	 	39	  
		
	 Section 11.01 Satisfaction and Discharge of Indenture
	  	 	39	  
		
	 Section 11.02 Discharge of Obligations
	  	 	40	  
		
	 Section 11.03 Deposited Moneys to be Held in Trust
	  	 	40	  
		
	 Section 11.04 Payment of Moneys Held by Paying Agents
	  	 	40	  
		
	 Section 11.05 Repayment to Company
	  	 	40	  
		
	 ARTICLE 12 IMMUNITY OF INCORPORATORS, STOCKHOLDERS, OFFICERS AND DIRECTORS
	  	 	41	  
		
	 Section 12.01 No Recourse
	  	 	41	  
		
	 ARTICLE 13 MISCELLANEOUS PROVISIONS
	  	 	41	  
		
	 Section 13.01 Effect on Successors and Assigns
	  	 	41	  
		
	 Section 13.02 Actions by Successor
	  	 	41	  
		
	 Section 13.03 Surrender of Company Powers
	  	 	42	  

  
 -iii-

 TABLE OF CONTENTS 

(CONTINUED) 
  

					
	 	  	PAGE	 
	 Section 13.04 Notices
	  	 	42	  
		
	 Section 13.05 Governing Law
	  	 	42	  
		
	 Section 13.06 Treatment of Securities as Debt
	  	 	42	  
		
	 Section 13.07 Certificates and Opinions as to Conditions Precedent
	  	 	42	  
		
	 Section 13.08 Payments on Business Days
	  	 	43	  
		
	 Section 13.09 Conflict with Trust Indenture Act
	  	 	43	  
		
	 Section 13.10 Counterparts
	  	 	43	  
		
	 Section 13.11 Separability
	  	 	43	  
		
	 Section 13.12 Compliance Certificates
	  	 	43	  

  
 -iv-

 INDENTURE 
 INDENTURE, dated as of [ • ], 201___, between INOVIO PHARMACEUTICALS, INC., a Delaware corporation (the
“Company”), and [TRUSTEE], as trustee (the “Trustee”): 

WHEREAS, for its lawful corporate purposes, the Company has duly authorized the execution and
delivery of this Indenture to provide for the issuance of debt securities (hereinafter referred to as the “Securities”), in an unlimited aggregate principal amount to be issued from time to time in one or more series as in this Indenture
provided, as registered Securities without coupons, to be authenticated by the certificate of the Trustee; 

WHEREAS, to provide the terms and conditions upon which the Securities are to be authenticated,
issued and delivered, the Company has duly authorized the execution of this Indenture; and 

WHEREAS, all things necessary to make this Indenture a valid agreement of the Company, in accordance
with its terms, have been done. 
 NOW, THEREFORE, in consideration of the
premises and the purchase of the Securities by the holders thereof, it is mutually covenanted and agreed as follows for the equal and ratable benefit of the holders of Securities: 

ARTICLE 1 

DEFINITIONS 
 Section 1.01 Definitions of Terms. 
 The terms defined in this Section
(except as in this Indenture or any indenture supplemental hereto otherwise expressly provided or unless the context otherwise requires) for all purposes of this Indenture and of any indenture supplemental hereto shall have the respective meanings
specified in this Section and shall include the plural as well as the singular. All other terms used in this Indenture that are defined in the Trust Indenture Act of 1939, as amended, or that are by reference in such Act defined in the Securities
Act of 1933, as amended (except as herein or any indenture supplemental hereto otherwise expressly provided or unless the context otherwise requires), shall have the meanings assigned to such terms in said Trust Indenture Act and in said Securities
Act as in force at the date of the execution of this instrument. 
 “Authenticating Agent” means an
authenticating agent with respect to all or any of the series of Securities appointed by the Trustee pursuant to Section 2.10. 
 “Bankruptcy Law” means Title 11, U.S. Code, or any similar federal or state law for the relief of debtors. 
 “Board of Directors” means the Board of Directors of the Company or any duly authorized committee of such Board. 

  
 1 

 “Board Resolution” means a copy of a resolution certified by the
Secretary or an Assistant Secretary of the Company to have been duly adopted by the Board of Directors and to be in full force and effect on the date of such certification. 
 “Business Day” means, with respect to any series of Securities, any day other than a day on which federal or state banking institutions in the Borough of Manhattan, the City of New
York, or in the city of the Corporate Trust Office of the Trustee, are authorized or obligated by law, executive order or regulation to close. 
 “Certificate” means a certificate signed by any Officer. The Certificate need not comply with the provisions of Section 13.07. 

“Company” means Inovio Pharmaceuticals, Inc., a corporation duly organized and existing under the laws of the
State of Delaware, and, subject to the provisions of Article Ten, shall also include its successors and assigns. 

“Corporate Trust Office” means the office of the Trustee at which, at any particular time, its corporate trust
business shall be principally administered, which office at the date hereof is located at [            ]. 
 “Custodian” means any receiver, trustee, assignee, liquidator or similar official under any Bankruptcy Law. 

“Default” means any event, act or condition that with notice or lapse of time, or both, would constitute an Event
of Default. 
 “Depositary” means, with respect to Securities of any series for which the Company shall
determine that such Securities will be issued as a Global Security, The Depository Trust Company, New York, New York, another clearing agency, or any successor registered as a clearing agency under the Securities and Exchange Act of 1934, as amended
(the “Exchange Act”), or other applicable statute or regulation, which, in each case, shall be designated by the Company pursuant to either Section 2.01 or 2.11. 

“Event of Default” means, with respect to Securities of a particular series, any event specified in
Section 6.01, continued for the period of time, if any, therein designated. 
 “Global Security”
means, with respect to any series of Securities, a Security executed by the Company and delivered by the Trustee to the Depositary or pursuant to the Depositary’s instruction, all in accordance with the Indenture, which shall be registered in
the name of the Depositary or its nominee. 
 “Governmental Obligations” means securities that are
(a) direct obligations of the United States of America for the payment of which its full faith and credit is pledged or (b) obligations of a Person controlled or supervised by and acting as an agency or instrumentality of the United States
of America, the payment of which is unconditionally guaranteed as a full faith and credit obligation by the United States of America that, in either case, are not callable or redeemable at the option of the issuer thereof at any time prior to the
stated maturity of the Securities, and shall also include a depositary receipt issued by a bank or trust company as custodian with respect to 

  
 2 

 
any such Governmental Obligation or a specific payment of principal of or interest on any such Governmental Obligation held by such custodian for the account of the holder of such depositary
receipt; provided, however, that (except as required by law) such custodian is not authorized to make any deduction from the amount payable to the holder of such depositary receipt from any amount received by the custodian in respect of the
Governmental Obligation or the specific payment of principal of or interest on the Governmental Obligation evidenced by such depositary receipt. 
 “herein”, “hereof” and “hereunder”, and other words of similar import, refer to this Indenture as a whole and not to any
particular Article, Section or other subdivision. 
 “Indenture” means this instrument as originally
executed or as it may from time to time be supplemented or amended by one or more indentures supplemental hereto entered into in accordance with the terms hereof. 
 “Interest Payment Date”, when used with respect to any installment of interest on a Security of a particular series, means the date specified in such Security or in a Board
Resolution or in an indenture supplemental hereto with respect to such series as the fixed date on which an installment of interest with respect to Securities of that series is due and payable. 

“Officer” means, with respect to the Company, the chairman of the Board of Directors, a chief executive officer,
a president, a chief financial officer, a chief operating officer, any executive vice president, any senior vice president, any vice president, the treasurer or any assistant treasurer, the controller or any assistant controller or the secretary or
any assistant secretary. 
 “Officers’ Certificate” means a certificate signed by any two Officers.
Each such certificate shall include the statements provided for in Section 13.07, if and to the extent required by the provisions thereof. 
 “Opinion of Counsel” means an opinion in writing subject to customary exceptions of legal counsel, who may be an employee of or counsel for the Company, that is delivered to the
Trustee in accordance with the terms hereof. Each such opinion shall include the statements provided for in Section 13.07, if and to the extent required by the provisions thereof. 

“Outstanding”, when used with reference to Securities of any series, means, subject to the provisions of
Section 8.04, as of any particular time, all Securities of that series theretofore authenticated and delivered by the Trustee under this Indenture, except (a) Securities theretofore canceled by the Trustee or any paying agent, or delivered
to the Trustee or any paying agent for cancellation or that have previously been canceled; (b) Securities or portions thereof for the payment or redemption of which moneys or Governmental Obligations in the necessary amount shall have been
deposited in trust with the Trustee or with any paying agent (other than the Company) or shall have been set aside and segregated in trust by the Company (if the Company shall act as its own paying agent); provided, however, that if such Securities
or portions of such Securities are to be redeemed prior to the maturity thereof, notice of such redemption shall have been given as in Article Three provided, or provision satisfactory to the Trustee shall have been

  
 3 

 
made for giving such notice; and (c) Securities in lieu of or in substitution for which other Securities shall have been authenticated and delivered pursuant to the terms of
Section 2.07. 
 “Person” means any individual, corporation, partnership, joint venture,
joint-stock company, limited liability company, association, trust, unincorporated organization, any other entity or organization, including a government or political subdivision or an agency or instrumentality thereof. 

“Predecessor Security” of any particular Security means every previous Security evidencing all or a portion of
the same debt as that evidenced by such particular Security; and, for the purposes of this definition, any Security authenticated and delivered under Section 2.07 in lieu of a lost, destroyed or stolen Security shall be deemed to evidence the
same debt as the lost, destroyed or stolen Security. 
 “Responsible Officer” when used with respect to
the Trustee means the chairman of its board of directors, the chief executive officer, the president, any vice president, the secretary, the treasurer, any trust officer, any corporate trust officer or any other officer or assistant officer of the
Trustee customarily performing functions similar to those performed by the Persons who at the time shall be such officers, respectively, or to whom any corporate trust matter is referred because of his or her knowledge of and familiarity with the
particular subject. 
 “Securities” means the debt Securities authenticated and delivered under this
Indenture. 
 “Securityholder”, “holder of Securities”, “registered
holder”, or other similar term, means the Person or Persons in whose name or names a particular Security shall be registered on the books of the Company kept for that purpose in accordance with the terms of this Indenture. 

“Security Register” and “Security Registrar” shall have the meanings as set forth in
Section 2.05. 
 “Subsidiary” means, with respect to any Person, (i) any corporation at least
a majority of whose outstanding Voting Stock shall at the time be owned, directly or indirectly, by such Person or by one or more of its Subsidiaries or by such Person and one or more of its Subsidiaries, (ii) any general partnership, joint
venture or similar entity, at least a majority of whose outstanding partnership or similar interests shall at the time be owned by such Person, or by one or more of its Subsidiaries, or by such Person and one or more of its Subsidiaries and
(iii) any limited partnership of which such Person or any of its Subsidiaries is a general partner. 

“Trustee” means [            ], and, subject
to the provisions of Article Seven, shall also include its successors and assigns, and, if at any time there is more than one Person acting in such capacity hereunder, “Trustee” shall mean each such Person. The term “Trustee” as
used with respect to a particular series of the Securities shall mean the trustee with respect to that series. 

“Trust Indenture Act” means the Trust Indenture Act of 1939, as amended. 

“Voting Stock”, as applied to stock of any Person, means shares, interests, participations or other equivalents
in the equity interest (however designated) in such Person having ordinary voting power for the election of a majority of the directors (or the equivalent) of such Person, 

  
 4 

 
other than shares, interests, participations or other equivalents having such power only by reason of the occurrence of a contingency. 

ARTICLE 2 

ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION AND EXCHANGE OF SECURITIES 

Section 2.01 Designation and Terms of Securities. 

(a) The aggregate principal amount of Securities that may be authenticated and delivered under this Indenture is
unlimited. The Securities may be issued in one or more series up to the aggregate principal amount of Securities of that series from time to time authorized by or pursuant to a Board Resolution or pursuant to one or more indentures supplemental
hereto. Prior to the initial issuance of Securities of any series, there shall be established in or pursuant to a Board Resolution, and set forth in an Officers’ Certificate, or established in one or more indentures supplemental hereto:

 (1) the title of the Securities of the series (which shall distinguish the Securities of that series
from all other Securities); 
 (2) any limit upon the aggregate principal amount of the Securities of that
series that may be authenticated and delivered under this Indenture (except for Securities authenticated and delivered upon registration of transfer of, or in exchange for, or in lieu of, other Securities of that series); 

(3) the date or dates on which the principal of the Securities of the series is payable, any original issue
discount that may apply to the Securities of that series upon their issuance, the principal amount due at maturity, and the place(s) of payment; 
 (4) the rate or rates at which the Securities of the series shall bear interest or the manner of calculation of such rate or rates, if any; 

(5) the date or dates from which such interest shall accrue, the Interest Payment Dates on which such interest will
be payable or the manner of determination of such Interest Payment Dates, the place(s) of payment, and the record date for the determination of holders to whom interest is payable on any such Interest Payment Dates or the manner of determination of
such record dates; 
 (6) the right, if any, to extend the interest payment periods and the duration of
such extension; 
 (7) the period or periods within which, the price or prices at which and the terms and
conditions upon which Securities of the series may be redeemed, in whole or in part, at the option of the Company; 
 (8) the obligation, if any, of the Company to redeem or purchase Securities of the series pursuant to any sinking fund, mandatory redemption, or analogous provisions (including payments made in
cash in satisfaction of future sinking fund obligations) 

  
 5 

 
or at the option of a holder thereof and the period or periods within which, the price or prices at which, and the terms and conditions upon which, Securities of the series shall be redeemed or
purchased, in whole or in part, pursuant to such obligation; 
 (9) the form of the Securities of the
series including the form of the Certificate of Authentication for such series; 
 (10) if other than
denominations of one thousand U.S. dollars ($1,000) or any integral multiple thereof, the denominations in which the Securities of the series shall be issuable; 
 (11) any and all other terms (including terms, to the extent applicable, relating to any auction or remarketing of the Securities of that series and any security for the obligations of the Company
with respect to such Securities) with respect to such series (which terms shall not be inconsistent with the terms of this Indenture, as amended by any supplemental indenture) including any terms which may be required by or advisable under United
States laws or regulations or advisable in connection with the marketing of Securities of that series; 

(12) whether the Securities are issuable as a Global Security and, in such case, the terms and the identity of the
Depositary for such series; 
 (13) whether the Securities will be convertible into or exchangeable for
shares of common stock or other securities of the Company or any other Person and, if so, the terms and conditions upon which such Securities will be so convertible or exchangeable, including the conversion or exchange price, as applicable, or how
it will be calculated and may be adjusted, any mandatory or optional (at the Company’s option or the holders’ option) conversion or exchange features, and the applicable conversion or exchange period; 

(14) if other than the principal amount thereof, the portion of the principal amount of Securities of the series
which shall be payable upon declaration of acceleration of the maturity thereof pursuant to Section 6.01; 

(15) any additional or different Events of Default or restrictive covenants (which may include, among other
restrictions, restrictions on the Company’s ability or the ability of the Company’s Subsidiaries to: incur additional indebtedness; issue additional securities; create liens; pay dividends or make distributions in respect of their capital
stock; redeem capital stock; place restrictions on such Subsidiaries placing restrictions on their ability to pay dividends, make distributions or transfer assets; make investments or other restricted payments; sell or otherwise dispose of assets;
enter into sale-leaseback transactions; engage in transactions with stockholders and affiliates; issue or sell stock of their Subsidiaries; or effect a consolidation or merger) or financial covenants (which may include, among other financial
covenants, financial covenants that require the Company and its Subsidiaries to maintain specified interest coverage, fixed charge, cash flow-based or asset-based ratios) provided for with respect to the Securities of the series; 

(16) if other than dollars, the coin or currency in which the Securities of the series are denominated (including,
but not limited to, foreign currency); 

  
 6 

 (17) the terms and conditions, if any, upon which the Company shall
pay amounts in addition to the stated interest, premium, if any and principal amounts of the Securities of the series to any Securityholder that is not a “United States person” for federal tax purposes; and 

(18) any restrictions on transfer, sale or assignment of the Securities of the series. 

All Securities of any one series shall be substantially identical except as to denomination and except as may otherwise be provided in or
pursuant to any such Board Resolution or in any indentures supplemental hereto. 
 If any of the terms of the series are
established by action taken pursuant to a Board Resolution of the Company, a copy of an appropriate record of such action shall be certified by the secretary or an assistant secretary of the Company and delivered to the Trustee at or prior to the
delivery of the Officers’ Certificate of the Company setting forth the terms of the series. 
 Securities of any particular
series may be issued at various times, with different dates on which the principal or any installment of principal is payable, with different rates of interest, if any, or different methods by which rates of interest may be determined, with
different dates on which such interest may be payable and with different redemption dates. 
 Section 2.02 Form of Securities
and Trustee’s Certificate. 
 The Securities of any series and the Trustee’s certificate of authentication to be
borne by such Securities shall be substantially of the tenor and purport as set forth in one or more indentures supplemental hereto or as provided in a Board Resolution, and set forth in an Officers’ Certificate, and they may have such letters,
numbers or other marks of identification or designation and such legends or endorsements printed, lithographed or engraved thereon as the Company may deem appropriate and as are not inconsistent with the provisions of this Indenture, or as may be
required to comply with any law or with any rule or regulation made pursuant thereto or with any rule or regulation of any securities exchange on which Securities of that series may be listed, or to conform to usage. 

Section 2.03 Denominations: Provisions for Payment. 
 The Securities shall be issuable as registered Securities and in the denominations of one thousand U.S. dollars ($1,000) or any integral multiple thereof, subject to Section 2.01(a)(10). The
Securities of a particular series shall bear interest payable on the dates and at the rate specified with respect to that series. Subject to Section 2.01(a)(16), the principal of and the interest on the Securities of any series, as well as any
premium thereon in case of redemption thereof prior to maturity, shall be payable in the coin or currency of the United States of America that at the time is legal tender for public and private debt, at the office or agency of the Company maintained
for that purpose in the Borough of Manhattan, the City and State of New York. Each Security shall be dated the date of its authentication. Interest on the Securities shall be computed on the basis of a 360-day
year composed of twelve 30-day months. 

  
 7 

 The interest installment on any Security that is payable, and is punctually paid or duly
provided for, on any Interest Payment Date for Securities of that series shall be paid to the Person in whose name said Security (or one or more Predecessor Securities) is registered at the close of business on the regular record date for such
interest installment. In the event that any Security of a particular series or portion thereof is called for redemption and the redemption date is subsequent to a regular record date with respect to any Interest Payment Date and prior to such
Interest Payment Date, interest on such Security will be paid upon presentation and surrender of such Security as provided in Section 3.03. 
 Any interest on any Security that is payable, but is not punctually paid or duly provided for, on any Interest Payment Date for Securities of the same series (herein called “Defaulted Interest”)
shall forthwith cease to be payable to the registered holder on the relevant regular record date by virtue of having been such holder; and such Defaulted Interest shall be paid by the Company, at its election, as provided in clause (1) or
clause (2) below: 
 (1) The Company may make payment of any Defaulted Interest on Securities to the
Persons in whose names such Securities (or their respective Predecessor Securities) are registered at the close of business on a special record date for the payment of such Defaulted Interest, which shall be fixed in the following manner: the
Company shall notify the Trustee in writing of the amount of Defaulted Interest proposed to be paid on each such Security and the date of the proposed payment, and at the same time the Company shall deposit with the Trustee an amount of money equal
to the aggregate amount proposed to be paid in respect of such Defaulted Interest or shall make arrangements satisfactory to the Trustee for such deposit prior to the date of the proposed payment, such money when deposited to be held in trust for
the benefit of the Persons entitled to such Defaulted Interest as in this clause provided. Thereupon the Trustee shall fix a special record date for the payment of such Defaulted Interest which shall not be more than 15 nor less than 10 days prior
to the date of the proposed payment and not less than 10 days after the receipt by the Trustee of the notice of the proposed payment. The Trustee shall promptly notify the Company of such special record date and, in the name and at the expense of
the Company, shall cause notice of the proposed payment of such Defaulted Interest and the special record date therefor to be mailed, first class postage prepaid, to each Securityholder at his or her address as it appears in the Security Register
(as hereinafter defined), not less than 10 days prior to such special record date. Notice of the proposed payment of such Defaulted Interest and the special record date therefor having been mailed as aforesaid, such Defaulted Interest shall be paid
to the Persons in whose names such Securities (or their respective Predecessor Securities) are registered on such special record date. 
 (2) The Company may make payment of any Defaulted Interest on any Securities in any other lawful manner not inconsistent with the requirements of any securities exchange on which such Securities
may be listed, and upon such notice as may be required by such exchange, if, after notice given by the Company to the Trustee of the proposed payment pursuant to this clause, such manner of payment shall be deemed practicable by the Trustee.

 Unless otherwise set forth in a Board Resolution or one or more indentures supplemental hereto establishing the terms of any
series of Securities pursuant to Section 2.01 hereof, the term “regular record date” as used in this Section with respect to a series of Securities and any Interest Payment Date for such series shall mean either the fifteenth day of
the month immediately 

  
 8 

 
preceding the month in which an Interest Payment Date established for such series pursuant to Section 2.01 hereof shall occur, if such Interest Payment Date is the first day of a month, or
the first day of the month in which an Interest Payment Date established for such series pursuant to Section 2.01 hereof shall occur, if such Interest Payment Date is the fifteenth day of a month, whether or not such date is a Business Day.

 Subject to the foregoing provisions of this Section, each Security of a series delivered under this Indenture upon transfer
of or in exchange for or in lieu of any other Security of such series shall carry the rights to interest accrued and unpaid, and to accrue, that were carried by such other Security. 

Section 2.04 Execution and Authentications. 
 The Securities shall be signed on behalf of the Company by one of its Officers. Signatures may be in the form of a manual or facsimile signature. 

The Company may use the facsimile signature of any Person who shall have been an Officer, notwithstanding the fact that at the time the
Securities shall be authenticated and delivered or disposed of such Person shall have ceased to be such an officer of the Company. The Securities may contain such notations, legends or endorsements required by law, stock exchange rule or usage. Each
Security shall be dated the date of its authentication by the Trustee. 
 A Security shall not be valid until authenticated
manually by an authorized signatory of the Trustee, or by an Authenticating Agent. Such signature shall be conclusive evidence that the Security so authenticated has been duly authenticated and delivered hereunder and that the holder is entitled to
the benefits of this Indenture. At any time and from time to time after the execution and delivery of this Indenture, the Company may deliver Securities of any series executed by the Company to the Trustee for authentication, together with a written
order of the Company for the authentication and delivery of such Securities, signed by an Officer, and the Trustee in accordance with such written order shall authenticate and deliver such Securities. 

In authenticating such Securities and accepting the additional responsibilities under this Indenture in relation to such Securities, the
Trustee shall be entitled to receive, and (subject to Section 7.01) shall be fully protected in relying upon, an Opinion of Counsel stating that the form and terms thereof have been established in conformity with the provisions of this
Indenture. 
 The Trustee shall not be required to authenticate such Securities if the issue of such Securities pursuant to this
Indenture will affect the Trustee’s own rights, duties or immunities under the Securities and this Indenture or otherwise in a manner that is not reasonably acceptable to the Trustee. 

Section 2.05 Registration of Transfer and Exchange. 

(a) Securities of any series may be exchanged upon presentation thereof at the office or agency of the Company
designated for such purpose in the Borough of Manhattan, the City and State of New York, for other Securities of such series of authorized denominations, and for a like aggregate principal amount, upon payment of a sum sufficient to cover any tax or
other 

  
 9 

 
governmental charge in relation thereto, all as provided in this Section. In respect of any Securities so surrendered for exchange, the Company shall execute, the Trustee shall authenticate and
such office or agency shall deliver in exchange therefor the Security or Securities of the same series that the Securityholder making the exchange shall be entitled to receive, bearing numbers not contemporaneously outstanding. 

(b) The Company shall keep, or cause to be kept, at its office or agency designated for such purpose in the Borough
of Manhattan, the City and State of New York, or such other location designated by the Company, a register or registers (herein referred to as the “Security Register”) in which, subject to such reasonable regulations as it may prescribe,
the Company shall register the Securities and the transfers of Securities as in this Article provided and which at all reasonable times shall be open for inspection by the Trustee. The registrar for the purpose of registering Securities and transfer
of Securities as herein provided shall be appointed as authorized by Board Resolution (the “Security Registrar”). 

Upon surrender for transfer of any Security at the office or agency of the Company designated for such purpose, the Company shall
execute, the Trustee shall authenticate and such office or agency shall deliver in the name of the transferee or transferees a new Security or Securities of the same series as the Security presented for a like aggregate principal amount. 

All Securities presented or surrendered for exchange or registration of transfer, as provided in this Section, shall be accompanied (if
so required by the Company or the Security Registrar) by a written instrument or instruments of transfer, in form satisfactory to the Company or the Security Registrar, duly executed by the registered holder or by such holder’s duly authorized
attorney in writing. 
 (c) Except as provided pursuant to Section 2.01 pursuant to a Board
Resolution, and set forth in an Officers’ Certificate, or established in one or more indentures supplemental to this Indenture, no service charge shall be made for any exchange or registration of transfer of Securities, or issue of new
Securities in case of partial redemption of any series, but the Company may require payment of a sum sufficient to cover any tax or other governmental charge in relation thereto, other than exchanges pursuant to Section 2.06,
Section 3.03(b) and Section 9.04 not involving any transfer. 
 (d) The Company shall not be
required (i) to issue, exchange or register the transfer of any Securities during a period beginning at the opening of business 15 days before the day of the mailing of a notice of redemption of less than all the Outstanding Securities of the
same series and ending at the close of business on the day of such mailing, nor (ii) to register the transfer of or exchange any Securities of any series or portions thereof called for redemption, other than the unredeemed portion of any such
Securities being redeemed in part. The provisions of this Section 2.05 are, with respect to any Global Security, subject to Section 2.11 hereof. 
 Section 2.06 Temporary Securities. 
 Pending the preparation of definitive
Securities of any series, the Company may execute, and the Trustee shall authenticate and deliver, temporary Securities (printed, lithographed or typewritten) of any authorized denomination. Such temporary Securities shall be substantially in

  
 10 

 
the form of the definitive Securities in lieu of which they are issued, but with such omissions, insertions and variations as may be appropriate for temporary Securities, all as may be determined
by the Company. Every temporary Security of any series shall be executed by the Company and be authenticated by the Trustee upon the same conditions and in substantially the same manner, and with like effect, as the definitive Securities of such
series. Without unnecessary delay the Company will execute and will furnish definitive Securities of such series and thereupon any or all temporary Securities of such series may be surrendered in exchange therefor (without charge to the holders), at
the office or agency of the Company designated for the purpose in the Borough of Manhattan, the City and State of New York, and the Trustee shall authenticate and such office or agency shall deliver in exchange for such temporary Securities an equal
aggregate principal amount of definitive Securities of such series, unless the Company advises the Trustee to the effect that definitive Securities need not be executed and furnished until further notice from the Company. Until so exchanged, the
temporary Securities of such series shall be entitled to the same benefits under this Indenture as definitive Securities of such series authenticated and delivered hereunder. 
 Section 2.07 Mutilated, Destroyed, Lost or Stolen Securities. 
 In case any
temporary or definitive Security shall become mutilated or be destroyed, lost or stolen, the Company (subject to the next succeeding sentence) shall execute, and upon the Company’s request the Trustee (subject as aforesaid) shall authenticate
and deliver, a new Security of the same series, bearing a number not contemporaneously outstanding, in exchange and substitution for the mutilated Security, or in lieu of and in substitution for the Security so destroyed, lost or stolen. In every
case the applicant for a substituted Security shall furnish to the Company and the Trustee such security or indemnity as may be required by them to save each of them harmless, and, in every case of destruction, loss or theft, the applicant shall
also furnish to the Company and the Trustee evidence to their satisfaction of the destruction, loss or theft of the applicant’s Security and of the ownership thereof. The Trustee may authenticate any such substituted Security and deliver the
same upon the written request or authorization of any officer of the Company. Upon the issuance of any substituted Security, the Company may require the payment of a sum sufficient to cover any tax or other governmental charge that may be imposed in
relation thereto and any other expenses (including the fees and expenses of the Trustee) connected therewith. 
 In case any
Security that has matured or is about to mature shall become mutilated or be destroyed, lost or stolen, the Company may, instead of issuing a substitute Security, pay or authorize the payment of the same (without surrender thereof except in the case
of a mutilated Security) if the applicant for such payment shall furnish to the Company and the Trustee such security or indemnity as they may require to save them harmless, and, in case of destruction, loss or theft, evidence to the satisfaction of
the Company and the Trustee of the destruction, loss or theft of such Security and of the ownership thereof. 
 Every
replacement Security issued pursuant to the provisions of this Section shall constitute an additional contractual obligation of the Company whether or not the mutilated, destroyed, lost or stolen Security shall be found at any time, or be
enforceable by anyone, and shall be entitled to all the benefits of this Indenture equally and proportionately with any and all other Securities of the same series duly issued hereunder. All Securities shall be held and owned

  
 11 

 
upon the express condition that the foregoing provisions are exclusive with respect to the replacement or payment of mutilated, destroyed, lost or stolen Securities, and shall preclude (to the
extent lawful) any and all other rights or remedies, notwithstanding any law or statute existing or hereafter enacted to the contrary with respect to the replacement or payment of negotiable instruments or other securities without their surrender.

 Section 2.08 Cancellation. 
 All Securities surrendered for the purpose of payment, redemption, exchange or registration of transfer shall, if surrendered to the Company or any paying agent, be delivered to the Trustee for
cancellation, or, if surrendered to the Trustee, shall be cancelled by it, and no Securities shall be issued in lieu thereof except as expressly required or permitted by any of the provisions of this Indenture. On request of the Company at the time
of such surrender, the Trustee shall deliver to the Company canceled Securities held by the Trustee. In the absence of such request the Trustee may dispose of canceled Securities in accordance with its standard procedures and deliver a certificate
of disposition to the Company. If the Company shall otherwise acquire any of the Securities, however, such acquisition shall not operate as a redemption or satisfaction of the indebtedness represented by such Securities unless and until the same are
delivered to the Trustee for cancellation. 
 Section 2.09 Benefits of Indenture. 

Nothing in this Indenture or in the Securities, express or implied, shall give or be construed to give to any Person, other than the
parties hereto and the holders of the Securities any legal or equitable right, remedy or claim under or in respect of this Indenture, or under any covenant, condition or provision herein contained; all such covenants, conditions and provisions being
for the sole benefit of the parties hereto and of the holders of the Securities. 
 Section 2.10 Authenticating Agent.

 So long as any of the Securities of any series remain Outstanding there may be an Authenticating Agent for any or all
such series of Securities which the Trustee shall have the right to appoint. Said Authenticating Agent shall be authorized to act on behalf of the Trustee to authenticate Securities of such series issued upon exchange, transfer or partial redemption
thereof, and Securities so authenticated shall be entitled to the benefits of this Indenture and shall be valid and obligatory for all purposes as if authenticated by the Trustee hereunder. All references in this Indenture to the authentication of
Securities by the Trustee shall be deemed to include authentication by an Authenticating Agent for such series. Each Authenticating Agent shall be acceptable to the Company and shall be a corporation that has a combined capital and surplus, as most
recently reported or determined by it, sufficient under the laws of any jurisdiction under which it is organized or in which it is doing business to conduct a trust business, and that is otherwise authorized under such laws to conduct such business
and is subject to supervision or examination by federal or state authorities. If at any time any Authenticating Agent shall cease to be eligible in accordance with these provisions, it shall resign immediately. 

  
 12 

 Any Authenticating Agent may at any time resign by giving written notice of resignation to
the Trustee and to the Company. The Trustee may at any time (and upon request by the Company shall) terminate the agency of any Authenticating Agent by giving written notice of termination to such Authenticating Agent and to the Company. Upon
resignation, termination or cessation of eligibility of any Authenticating Agent, the Trustee may appoint an eligible successor Authenticating Agent acceptable to the Company. Any successor Authenticating Agent, upon acceptance of its appointment
hereunder, shall become vested with all the rights, powers and duties of its predecessor hereunder as if originally named as an Authenticating Agent pursuant hereto. 
 Section 2.11 Global Securities. 
 (a) If the Company
shall establish pursuant to Section 2.01 that the Securities of a particular series are to be issued as a Global Security, then the Company shall execute and the Trustee shall, in accordance with Section 2.04, authenticate and deliver, a
Global Security that (i) shall represent, and shall be denominated in an amount equal to the aggregate principal amount of, all of the Outstanding Securities of such series, (ii) shall be registered in the name of the Depositary or its
nominee, (iii) shall be delivered by the Trustee to the Depositary or pursuant to the Depositary’s instruction and (iv) shall bear a legend substantially to the following effect: “Except as otherwise provided in Section 2.11
of the Indenture, this Security may be transferred, in whole but not in part, only to another nominee of the Depositary or to a successor Depositary or to a nominee of such successor Depositary.” 

(b) Notwithstanding the provisions of Section 2.05, the Global Security of a series may be transferred, in
whole but not in part and in the manner provided in Section 2.05, only to another nominee of the Depositary for such series, or to a successor Depositary for such series selected or approved by the Company or to a nominee of such successor
Depositary. 
 (c) If at any time the Depositary for a series of the Securities notifies the Company that
it is unwilling or unable to continue as Depositary for such series or if at any time the Depositary for such series shall no longer be registered or in good standing under the Exchange Act, or other applicable statute or regulation, and a successor
Depositary for such series is not appointed by the Company within 90 days after the Company receives such notice or becomes aware of such condition, as the case may be, or if an Event of Default has occurred and is continuing and the Company has
received a request from the Depositary, this Section 2.11 shall no longer be applicable to the Securities of such series and the Company will execute, and subject to Section 2.04, the Trustee will authenticate and deliver the Securities of
such series in definitive registered form without coupons, in authorized denominations, and in an aggregate principal amount equal to the principal amount of the Global Security of such series in exchange for such Global Security. In addition, the
Company may at any time determine that the Securities of any series shall no longer be represented by a Global Security and that the provisions of this Section 2.11 shall no longer apply to the Securities of such series. In such event the
Company will execute and, subject to Section 2.04, the Trustee, upon receipt of an Officers’ Certificate evidencing such determination by the Company, will authenticate and deliver the Securities of such series in definitive registered
form without coupons, in authorized denominations, and in an aggregate principal amount equal to the principal amount of the Global Security of such series in exchange for such Global Security. Upon the exchange of the Global

  
 13 

 
Security for such Securities in definitive registered form without coupons, in authorized denominations, the Global Security shall be canceled by the Trustee. Such Securities in definitive
registered form issued in exchange for the Global Security pursuant to this Section 2.11(c) shall be registered in such names and in such authorized denominations as the Depositary, pursuant to instructions from its direct or indirect
participants or otherwise, shall instruct the Trustee. The Trustee shall deliver such Securities to the Depositary for delivery to the Persons in whose names such Securities are so registered. 

ARTICLE 3 

REDEMPTION OF SECURITIES AND SINKING FUND PROVISIONS 
 Section 3.01 Redemption. 
 The Company may redeem the Securities of any
series issued hereunder on and after the dates and in accordance with the terms established for such series pursuant to Section 2.01 hereof. 
 Section 3.02 Notice of Redemption. 
 (a) In case the
Company shall desire to exercise such right to redeem all or, as the case may be, a portion of the Securities of any series in accordance with any right the Company reserved for itself to do so pursuant to Section 2.01 hereof, the Company
shall, or shall cause the Trustee to, give notice of such redemption to holders of the Securities of such series to be redeemed by mailing, first class postage prepaid, a notice of such redemption not less than 30 days and not more than 90 days
before the date fixed for redemption of that series to such holders at their last addresses as they shall appear upon the Security Register, unless a shorter period is specified in the Securities to be redeemed. Any notice that is mailed in the
manner herein provided shall be conclusively presumed to have been duly given, whether or not the registered holder receives the notice. In any case, failure duly to give such notice to the holder of any Security of any series designated for
redemption in whole or in part, or any defect in the notice, shall not affect the validity of the proceedings for the redemption of any other Securities of such series or any other series. In the case of any redemption of Securities prior to the
expiration of any restriction on such redemption provided in the terms of such Securities or elsewhere in this Indenture, the Company shall furnish the Trustee with an Officers’ Certificate evidencing compliance with any such restriction.

 Each such notice of redemption shall specify the date fixed for redemption and the redemption price at which Securities of
that series are to be redeemed, and shall state that payment of the redemption price of such Securities to be redeemed will be made at the office or agency of the Company in the Borough of Manhattan, the City and State of New York, upon presentation
and surrender of such Securities, that interest accrued to the date fixed for redemption will be paid as specified in said notice, that from and after said date interest will cease to accrue and that the redemption is for a sinking fund, if such is
the case. If less than all the Securities of a series are to be redeemed, the notice to the holders of Securities of that series to be redeemed in part shall specify the particular Securities to be so redeemed. 

  
 14 

 In case any Security is to be redeemed in part only, the notice that relates to such
Security shall state the portion of the principal amount thereof to be redeemed, and shall state that on and after the redemption date, upon surrender of such Security, a new Security or Securities of such series in principal amount equal to the
unredeemed portion thereof will be issued. 
 (b) If less than all the Securities of a series are to be
redeemed, the Company shall give the Trustee at least 45 days’ notice (unless a shorter notice shall be satisfactory to the Trustee) in advance of the date fixed for redemption as to the aggregate principal amount of Securities of the series to
be redeemed, and thereupon the Trustee shall select, by lot or in such other manner as it shall deem appropriate and fair in its discretion and that may provide for the selection of a portion or portions (equal to one thousand U.S. dollars ($1,000)
or any integral multiple thereof) of the principal amount of such Securities of a denomination larger than $1,000, the Securities to be redeemed and shall thereafter promptly notify the Company in writing of the numbers of the Securities to be
redeemed, in whole or in part. The Company may, if and whenever it shall so elect, by delivery of instructions signed on its behalf by an Officer, instruct the Trustee or any paying agent to call all or any part of the Securities of a particular
series for redemption and to give notice of redemption in the manner set forth in this Section, such notice to be in the name of the Company or its own name as the Trustee or such paying agent may deem advisable. In any case in which notice of
redemption is to be given by the Trustee or any such paying agent, the Company shall deliver or cause to be delivered to, or permit to remain with, the Trustee or such paying agent, as the case may be, such Security Register, transfer books or other
records, or suitable copies or extracts therefrom, sufficient to enable the Trustee or such paying agent to give any notice by mail that may be required under the provisions of this Section. 

Section 3.03 Payment Upon Redemption. 
 (a) If the giving of notice of redemption shall have been completed as above provided, the Securities or portions of Securities of the series to be redeemed specified in such notice shall become
due and payable on the date and at the place stated in such notice at the applicable redemption price, together with interest accrued to the date fixed for redemption and interest on such Securities or portions of Securities shall cease to accrue on
and after the date fixed for redemption, unless the Company shall default in the payment of such redemption price and accrued interest with respect to any such Security or portion thereof. On presentation and surrender of such Securities on or after
the date fixed for redemption at the place of payment specified in the notice, said Securities shall be paid and redeemed at the applicable redemption price for such series, together with interest accrued thereon to the date fixed for redemption
(but if the date fixed for redemption is an interest payment date, the interest installment payable on such date shall be payable to the registered holder at the close of business on the applicable record date pursuant to Section 2.03).

 (b) Upon presentation of any Security of such series that is to be redeemed in part only, the Company
shall execute and the Trustee shall authenticate and the office or agency where the Security is presented shall deliver to the holder thereof, at the expense of the Company, a new Security of the same series of authorized denominations in principal
amount equal to the unredeemed portion of the Security so presented. 

  
 15 

 Section 3.04 Sinking Fund. 

The provisions of Sections 3.04, 3.05 and 3.06 shall be applicable to any sinking fund for the retirement of Securities of a series,
except as otherwise specified as contemplated by Section 2.01 for Securities of such series. 
 The minimum amount of any
sinking fund payment provided for by the terms of Securities of any series is herein referred to as a “mandatory sinking fund payment,” and any payment in excess of such minimum amount provided for by the terms of Securities of any series
is herein referred to as an “optional sinking fund payment”. If provided for by the terms of Securities of any series, the cash amount of any sinking fund payment may be subject to reduction as provided in Section 3.05. Each sinking
fund payment shall be applied to the redemption of Securities of any series as provided for by the terms of Securities of such series. 
 Section 3.05 Satisfaction of Sinking Fund Payments with Securities. 
 The
Company (i) may deliver Outstanding Securities of a series and (ii) may apply as a credit Securities of a series that have been redeemed either at the election of the Company pursuant to the terms of such Securities or through the
application of permitted optional sinking fund payments pursuant to the terms of such Securities, in each case in satisfaction of all or any part of any sinking fund payment with respect to the Securities of such series required to be made pursuant
to the terms of such Securities as provided for by the terms of such series, provided that such Securities have not been previously so credited. Such Securities shall be received and credited for such purpose by the Trustee at the redemption price
specified in such Securities for redemption through operation of the sinking fund and the amount of such sinking fund payment shall be reduced accordingly. 
 Section 3.06 Redemption of Securities for Sinking Fund. 
 Not less than 45
days prior to each sinking fund payment date for any series of Securities (unless a shorter period shall be satisfactory to the Trustee), the Company will deliver to the Trustee an Officers’ Certificate specifying the amount of the next ensuing
sinking fund payment for that series pursuant to the terms of the series, the portion thereof, if any, that is to be satisfied by delivering and crediting Securities of that series pursuant to Section 3.05 and the basis for such credit and
will, together with such Officers’ Certificate, deliver to the Trustee any Securities to be so delivered. Not less than 30 days before each such sinking fund payment date the Trustee shall select the Securities to be redeemed upon such sinking
fund payment date in the manner specified in Section 3.02 and cause notice of the redemption thereof to be given in the name of and at the expense of the Company in the manner provided in Section 3.02. Such notice having been duly given,
the redemption of such Securities shall be made upon the terms and in the manner stated in Section 3.03. 

  
 16 

 ARTICLE 4 
 COVENANTS 
 Section 4.01 Payment of Principal, Premium and Interest.

 The Company will duly and punctually pay or cause to be paid the principal of (and premium, if any) and interest on the
Securities of that series at the time and place and in the manner provided herein and established with respect to such Securities. Payments of principal on the Securities may be made at the time provided herein and established with respect to such
Securities by U.S. dollar check drawn on and mailed to the address of the Securityholder entitled thereto as such address shall appear in the Security Register, or U.S. dollar wire transfer to, a U.S. dollar account (such wire transfer to be made
only to a Securityholder of an aggregate principal amount of Securities of the applicable series in excess of U.S. $2,000,000 and only if such Securityholder shall have furnished wire instructions to the Trustee no later than 15 days prior to the
relevant payment date). Payments of interest on the Securities may be made at the time provided herein and established with respect to such Securities by U.S. dollar check mailed to the address of the Securityholder entitled thereto as such address
shall appear in the Security Register, or U.S. dollar wire transfer to, a U.S. dollar account (such a wire transfer to be made only to a Securityholder of an aggregate principal amount of Securities of the applicable series in excess of U.S.
$2,000,000 and only if such Securityholder shall have furnished wire instructions in writing to the Security Registrar and the Trustee no later than 15 days prior to the relevant payment date. 

Section 4.02 Maintenance of Office or Agency. 
 So long as any series of the Securities remain Outstanding, the Company agrees to maintain an office or agency in the Borough of Manhattan, the City and State of New York, with respect to each such series
and at such other location or locations as may be designated as provided in this Section 4.02, where (i) Securities of that series may be presented for payment, (ii) Securities of that series may be presented as herein above
authorized for registration of transfer and exchange, and (iii) notices and demands to or upon the Company in respect of the Securities of that series and this Indenture may be given or served, such designation to continue with respect to such
office or agency until the Company shall, by written notice signed by any officer authorized to sign an Officers’ Certificate and delivered to the Trustee, designate some other office or agency for such purposes or any of them. If at any time
the Company shall fail to maintain any such required office or agency or shall fail to furnish the Trustee with the address thereof, such presentations, notices and demands may be made or served at the Corporate Trust Office of the Trustee, and the
Company hereby appoints the Trustee as its agent to receive all such presentations, notices and demands. The Company initially appoints the Corporate Trust Office of the Trustee located in the Borough of Manhattan, the City of New York as its paying
agent with respect to the Securities. 
 Section 4.03 Paying Agents. 

(a) If the Company shall appoint one or more paying agents for all or any series of the Securities, other than the
Trustee, the Company will cause each such paying agent to 

  
 17 

 
execute and deliver to the Trustee an instrument in which such agent shall agree with the Trustee, subject to the provisions of this Section: 

(1) that it will hold all sums held by it as such agent for the payment of the principal of (and premium, if any)
or interest on the Securities of that series (whether such sums have been paid to it by the Company or by any other obligor of such Securities) in trust for the benefit of the Persons entitled thereto; 

(2) that it will give the Trustee notice of any failure by the Company (or by any other obligor of such Securities)
to make any payment of the principal of (and premium, if any) or interest on the Securities of that series when the same shall be due and payable; 
 (3) that it will, at any time during the continuance of any failure referred to in the preceding paragraph (a)(2) above, upon the written request of the Trustee, forthwith pay to the Trustee
all sums so held in trust by such paying agent; and 
 (4) that it will perform all other duties of paying
agent as set forth in this Indenture. 
 (b) If the Company shall act as its own paying agent with respect
to any series of the Securities, it will on or before each due date of the principal of (and premium, if any) or interest on Securities of that series, set aside, segregate and hold in trust for the benefit of the Persons entitled thereto a sum
sufficient to pay such principal (and premium, if any) or interest so becoming due on Securities of that series until such sums shall be paid to such Persons or otherwise disposed of as herein provided and will promptly notify the Trustee of such
action, or any failure (by it or any other obligor on such Securities) to take such action. Whenever the Company shall have one or more paying agents for any series of Securities, it will, prior to each due date of the principal of (and premium, if
any) or interest on any Securities of that series, deposit with the paying agent a sum sufficient to pay the principal (and premium, if any) or interest so becoming due, such sum to be held in trust for the benefit of the Persons entitled to such
principal, premium or interest, and (unless such paying agent is the Trustee) the Company will promptly notify the Trustee of this action or failure so to act. 
 (c) Notwithstanding anything in this Section to the contrary, (i) the agreement to hold sums in trust as provided in this Section is subject to the provisions of Section 11.05, and
(ii) the Company may at any time, for the purpose of obtaining the satisfaction and discharge of this Indenture or for any other purpose, pay, or direct any paying agent to pay, to the Trustee all sums held in trust by the Company or such
paying agent, such sums to be held by the Trustee upon the same terms and conditions as those upon which such sums were held by the Company or such paying agent; and, upon such payment by the Company or any paying agent to the Trustee, the Company
or such paying agent shall be released from all further liability with respect to such money. 

  
 18 

 Section 4.04 Appointment to Fill Vacancy in Office of Trustee. 

The Company, whenever necessary to avoid or fill a vacancy in the office of Trustee, will appoint, in the manner provided in
Section 7.10, a Trustee, so that there shall at all times be a Trustee hereunder. 
 Section 4.05 Compliance with
Consolidation Provisions. 
 The Company will not, while any of the Securities remain Outstanding, consolidate with or merge
into any other Person, in either case where the Company is not the survivor of such transaction, or sell or convey all or substantially all of its property to any other Person unless the provisions of Article Ten hereof are complied with.

 ARTICLE 5 
 SECURITYHOLDERS’ LISTS AND REPORTS BY THE COMPANY AND THE TRUSTEE 

Section 5.01 Company to Furnish Trustee Names and Addresses of Securityholders. 

The Company will furnish or cause to be furnished to the Trustee (a) within 15 days after each regular record date (as defined in
Section 2.03) a list, in such form as the Trustee may reasonably require, of the names and addresses of the holders of each series of Securities as of such regular record date, provided that the Company shall not be obligated to furnish or
cause to furnish such list at any time that the list shall not differ in any respect from the most recent list furnished to the Trustee by the Company and (b) at such other times as the Trustee may request in writing within 30 days after the
receipt by the Company of any such request, a list of similar form and content as of a date not more than 15 days prior to the time such list is furnished; provided, however, that, in either case, no such list need be furnished for any series for
which the Trustee shall be the Security Registrar. 
 Section 5.02 Preservation Of Information; Communications With
Securityholders. 
 (a) The Trustee shall preserve, in as current a form as is reasonably practicable,
all information as to the names and addresses of the holders of Securities contained in the most recent list furnished to it as provided in Section 5.01 and as to the names and addresses of holders of Securities received by the Trustee in its
capacity as Security Registrar (if acting in such capacity). 
 (b) The Trustee may destroy any list
furnished to it as provided in Section 5.01 upon receipt of a new list so furnished. 
 (c)
Securityholders may communicate as provided in Section 312(b) of the Trust Indenture Act with other Securityholders with respect to their rights under this Indenture or under the Securities, and, in connection with any such communications, the
Trustee shall satisfy its obligations under Section 312(b) of the Trust Indenture Act in accordance with the provisions of Section 312(b) of the Trust Indenture Act. 

  
 19 

 Section 5.03 Reports by the Company. 

The Company covenants and agrees to provide a copy to the Trustee, after the Company files the same with the Securities and Exchange
Commission, copies of the annual reports and of the information, documents and other reports (or copies of such portions of any of the foregoing as the Securities and Exchange Commission may from time to time by rules and regulations prescribe) that
the Company files with the Securities and Exchange Commission pursuant to Section 13 or Section 15(d) of the Exchange Act; provided, however, the Company shall not be required to deliver to the Trustee any materials for which the Company
has sought and received confidential treatment by the Securities and Exchange Commission. 
 Section 5.04 Reports by the
Trustee. 
 (a) If required by Section 313(a) of the Trust Indenture Act, the Trustee, within
sixty (60) days after each May 1, shall transmit by mail, first class postage prepaid, to the Securityholders, as their names and addresses appear upon the Security Register, a brief report dated as of such May 1, which complies with
Section 313(a) of the Trust Indenture Act. 
 (b) The Trustee shall comply with Section 313(b)
and 313(c) of the Trust Indenture Act. 
 (c) A copy of each such report shall, at the time of such
transmission to Securityholders, be filed by the Trustee with the Company, with each securities exchange upon which any Securities are listed (if so listed) and also with the Securities and Exchange Commission. The Company agrees to notify the
Trustee when any Securities become listed on any securities exchange. 
 ARTICLE 6 

REMEDIES OF THE TRUSTEE AND SECURITYHOLDERS ON EVENT OF DEFAULT 

Section 6.01 Events of Default. 
 (a) Whenever used herein with respect to Securities of a particular series, “Event of Default” means any one or more of the following events that has occurred and is continuing:

 (1) the Company defaults in the payment of any installment of interest upon any of the Securities of
that series, as and when the same shall become due and payable, and such default continues for a period of 90 days; provided, however, that a valid extension of an interest payment period by the Company in accordance with the terms of any indenture
supplemental hereto shall not constitute a default in the payment of interest for this purpose; 
 (2) the
Company defaults in the payment of the principal of (or premium, if any, on) any of the Securities of that series as and when the same shall become due and payable whether at maturity, upon redemption, by declaration or otherwise, or in any payment
required by any sinking or analogous fund established with respect to that series; provided, however, that a valid extension of the maturity of such Securities in accordance with 

  
 20 

 
the terms of any indenture supplemental hereto shall not constitute a default in the payment of principal or premium, if any; 

(3) the Company fails to observe or perform any other of its covenants or agreements with respect to that series
contained in this Indenture or otherwise established with respect to that series of Securities pursuant to Section 2.01 hereof (other than a covenant or agreement that has been expressly included in this Indenture solely for the benefit of one
or more series of Securities other than such series) for a period of 90 days after the date on which written notice of such failure, requiring the same to be remedied and stating that such notice is a “Notice of Default” hereunder, shall
have been given to the Company by the Trustee, by registered or certified mail, or to the Company and the Trustee by the holders of at least 25% in principal amount of the Securities of that series at the time Outstanding; 

(4) the Company pursuant to or within the meaning of any Bankruptcy Law (i) commences a voluntary case,
(ii) consents to the entry of an order for relief against it in an involuntary case, (iii) consents to the appointment of a Custodian of it or for all or substantially all of its property or (iv) makes a general assignment for the
benefit of its creditors; or 
 (5) a court of competent jurisdiction enters an order under any Bankruptcy
Law that (i) is for relief against the Company in an involuntary case, (ii) appoints a Custodian of the Company for all or substantially all of its property or (iii) orders the liquidation of the Company, and the order or decree
remains unstayed and in effect for 90 days. 
 (b) In each and every such case (other than an Event of
Default specified in clause (4) or clause (5) above), unless the principal of all the Securities of that series shall have already become due and payable, either the Trustee or the holders of not less than 25% in aggregate principal amount
of the Securities of that series then Outstanding hereunder, by notice in writing to the Company (and to the Trustee if given by such Securityholders), may declare the principal of (and premium, if any, on) and accrued and unpaid interest on all the
Securities of that series to be due and payable immediately, and upon any such declaration the same shall become and shall be immediately due and payable. If an Event of Default specified in clause (4) or clause (5) above occurs, the
principal of and accrued and unpaid interest on all the Securities of that series shall automatically be immediately due and payable without any declaration or other act on the part of the Trustee or the holders of the Securities. 

(c) At any time after the principal of (and premium, if any, on) and accrued and unpaid interest on the Securities
of that series shall have been so declared due and payable, and before any judgment or decree for the payment of the moneys due shall have been obtained or entered as hereinafter provided, the holders of a majority in aggregate principal amount of
the Securities of that series then Outstanding hereunder, by written notice to the Company and the Trustee, may rescind and annul such declaration and its consequences if: (i) the Company has paid or deposited with the Trustee a sum sufficient
to pay all matured installments of interest upon all the Securities of that series and the principal of (and premium, if any, on) any and all Securities of that series that shall have become due otherwise than by acceleration (with interest upon
such principal and premium, if any, and, to the extent that such payment is enforceable under applicable law, upon overdue installments of interest, at the rate per annum expressed in 

  
 21 

 
the Securities of that series to the date of such payment or deposit) and the amount payable to the Trustee under Section 7.06, and (ii) any and all Events of Default under the
Indenture with respect to such series, other than the nonpayment of principal on (and premium, if any, on) and accrued and unpaid interest on Securities of that series that shall not have become due by their terms, shall have been remedied or waived
as provided in Section 6.06. 
 No such rescission and annulment shall extend to or shall affect any subsequent default or
impair any right consequent thereon. 
 (d) In case the Trustee shall have proceeded to enforce any right
with respect to Securities of that series under this Indenture and such proceedings shall have been discontinued or abandoned because of such rescission or annulment or for any other reason or shall have been determined adversely to the Trustee,
then and in every such case, subject to any determination in such proceedings, the Company and the Trustee shall be restored respectively to their former positions and rights hereunder, and all rights, remedies and powers of the Company and the
Trustee shall continue as though no such proceedings had been taken. 
 Section 6.02 Collection of Indebtedness and Suits for
Enforcement by Trustee. 
 (a) The Company covenants that (i) in case it shall default in the
payment of any installment of interest on any of the Securities of a series, or in any payment required by any sinking or analogous fund established with respect to that series as and when the same shall have become due and payable, and such default
shall have continued for a period of 90 days, or (ii) in case it shall default in the payment of the principal of (or premium, if any, on) any of the Securities of a series when the same shall have become due and payable, whether upon maturity
of the Securities of a series or upon redemption or upon declaration or otherwise then, upon demand of the Trustee, the Company will pay to the Trustee, for the benefit of the holders of the Securities of that series, the whole amount that then
shall have been become due and payable on all such Securities for principal (and premium, if any) or interest, or both, as the case may be, with interest upon the overdue principal (and premium, if any) and (to the extent that payment of such
interest is enforceable under applicable law) upon overdue installments of interest at the rate per annum expressed in the Securities of that series; and, in addition thereto, such further amount as shall be sufficient to cover the costs and
expenses of collection, and the amount payable to the Trustee under Section 7.06. 
 (b) If the
Company shall fail to pay such amounts forthwith upon such demand, the Trustee, in its own name and as trustee of an express trust, shall be entitled and empowered to institute any action or proceedings at law or in equity for the collection of the
sums so due and unpaid, and may prosecute any such action or proceeding to judgment or final decree, and may enforce any such judgment or final decree against the Company or other obligor upon the Securities of that series and collect the moneys
adjudged or decreed to be payable in the manner provided by law or equity out of the property of the Company or other obligor upon the Securities of that series, wherever situated. 

(c) In case of any receivership, insolvency, liquidation, bankruptcy, reorganization, readjustment, arrangement,
composition or judicial proceedings affecting the Company, or its creditors or property, the Trustee shall have power to intervene in such 

  
 22 

 
proceedings and take any action therein that may be permitted by the court and shall (except as may be otherwise provided by law) be entitled to file such proofs of claim and other papers and
documents as may be necessary or advisable in order to have the claims of the Trustee and of the holders of Securities of such series allowed for the entire amount due and payable by the Company under the Indenture at the date of institution of such
proceedings and for any additional amount that may become due and payable by the Company after such date, and to collect and receive any moneys or other property payable or deliverable on any such claim, and to distribute the same after the
deduction of the amount payable to the Trustee under Section 7.06; and any receiver, assignee or trustee in bankruptcy or reorganization is hereby authorized by each of the holders of Securities of such series to make such payments to the
Trustee, and, in the event that the Trustee shall consent to the making of such payments directly to such Securityholders, to pay to the Trustee any amount due it under Section 7.06. 

(d) All rights of action and of asserting claims under this Indenture, or under any of the terms established with
respect to Securities of that series, may be enforced by the Trustee without the possession of any of such Securities, or the production thereof at any trial or other proceeding relative thereto, and any such suit or proceeding instituted by the
Trustee shall be brought in its own name as trustee of an express trust, and any recovery of judgment shall, after provision for payment to the Trustee of any amounts due under Section 7.06, be for the ratable benefit of the holders of the
Securities of such series. 
 In case of an Event of Default hereunder, the Trustee may in its discretion proceed to protect and
enforce the rights vested in it by this Indenture by such appropriate judicial proceedings as the Trustee shall deem most effectual to protect and enforce any of such rights, either at law or in equity or in bankruptcy or otherwise, whether for the
specific enforcement of any covenant or agreement contained in the Indenture or in aid of the exercise of any power granted in this Indenture, or to enforce any other legal or equitable right vested in the Trustee by this Indenture or by law.

 Nothing contained herein shall be deemed to authorize the Trustee to authorize or consent to or accept or adopt on behalf of
any Securityholder any plan of reorganization, arrangement, adjustment or composition affecting the Securities of that series or the rights of any holder thereof or to authorize the Trustee to vote in respect of the claim of any Securityholder in
any such proceeding. 
 Section 6.03 Application of Moneys Collected. 

Any moneys collected by the Trustee pursuant to this Article with respect to a particular series of Securities shall be applied in the
following order, at the date or dates fixed by the Trustee and, in case of the distribution of such moneys on account of principal (or premium, if any) or interest, upon presentation of the Securities of that series, and notation thereon of the
payment, if only partially paid, and upon surrender thereof if fully paid: 
 FIRST: To the payment of reasonable costs and
expenses of collection and of all amounts payable to the Trustee under Section 7.06; 

  
 23 

 SECOND: To the payment of the amounts then due and unpaid upon Securities of such series for
principal (and premium, if any) and interest, in respect of which or for the benefit of which such money has been collected, ratably, without preference or priority of any kind, according to the amounts due and payable on such Securities for
principal (and premium, if any) and interest, respectively; and 
 THIRD: To the payment of the remainder, if any, to the
Company or any other Person lawfully entitled thereto. 
 Section 6.04 Limitation on Suits. 

No holder of any Security of any series shall have any right by virtue or by availing of any provision of this Indenture to institute any
suit, action or proceeding in equity or at law upon or under or with respect to this Indenture or for the appointment of a receiver or trustee, or for any other remedy hereunder, unless (i) such holder previously shall have given to the Trustee
written notice of an Event of Default and of the continuance thereof with respect to the Securities of such series specifying such Event of Default, as hereinbefore provided; (ii) the holders of not less than 25% in aggregate principal amount
of the Securities of such series then Outstanding shall have made written request upon the Trustee to institute such action, suit or proceeding in its own name as Trustee hereunder; (iii) such holder or holders shall have offered to the Trustee
such reasonable indemnity as it may require against the costs, expenses and liabilities to be incurred therein or thereby; (iv) the Trustee for 90 days after its receipt of such notice, request and offer of indemnity, shall have failed to
institute any such action, suit or proceeding and (v) during such 90 day period, the holders of a majority in principal amount of the Securities of that series do not give the Trustee a direction inconsistent with the request. 

Notwithstanding anything contained herein to the contrary or any other provisions of this Indenture, the right of any holder of any
Security to receive payment of the principal of (and premium, if any) and interest on such Security, as therein provided, on or after the respective due dates expressed in such Security (or in the case of redemption, on the redemption date), or to
institute suit for the enforcement of any such payment on or after such respective dates or redemption date, shall not be impaired or affected without the consent of such holder and by accepting a Security hereunder it is expressly understood,
intended and covenanted by the taker and holder of every Security of such series with every other such taker and holder and the Trustee, that no one or more holders of Securities of such series shall have any right in any manner whatsoever by virtue
or by availing of any provision of this Indenture to affect, disturb or prejudice the rights of the holders of any other of such Securities, or to obtain or seek to obtain priority over or preference to any other such holder, or to enforce any right
under this Indenture, except in the manner herein provided and for the equal, ratable and common benefit of all holders of Securities of such series. For the protection and enforcement of the provisions of this Section, each and every Securityholder
and the Trustee shall be entitled to such relief as can be given either at law or in equity. 
 Section 6.05 Rights and
Remedies Cumulative; Delay or Omission Not Waiver. 
 (a) Except as otherwise provided in
Section 2.07, all powers and remedies given by this Article to the Trustee or to the Securityholders shall, to the extent permitted by law, 

  
 24 

 
be deemed cumulative and not exclusive of any other powers and remedies available to the Trustee or the holders of the Securities, by judicial proceedings or otherwise, to enforce the performance
or observance of the covenants and agreements contained in this Indenture or otherwise established with respect to such Securities. 
 (b) No delay or omission of the Trustee or of any holder of any of the Securities to exercise any right or power accruing upon any Event of Default occurring and continuing as aforesaid shall
impair any such right or power, or shall be construed to be a waiver of any such default or an acquiescence therein; and, subject to the provisions of Section 6.04, every power and remedy given by this Article or by law to the Trustee or the
Securityholders may be exercised from time to time, and as often as shall be deemed expedient, by the Trustee or by the Securityholders. 
 Section 6.06 Control by Securityholders. 
 The holders of a majority in
aggregate principal amount of the Securities of any series at the time Outstanding, determined in accordance with Section 8.04, shall have the right to direct the time, method and place of conducting any proceeding for any remedy available to
the Trustee, or exercising any trust or power conferred on the Trustee with respect to such series; provided, however, that such direction shall not be in conflict with any rule of law or with this Indenture. Subject to the provisions of
Section 7.01, the Trustee shall have the right to decline to follow any such direction if the Trustee in good faith shall, by a Responsible Officer or officers of the Trustee, determine that the proceeding so directed, subject to the
Trustee’s duties under the Trust Indenture Act, would involve the Trustee in personal liability or might be unduly prejudicial to the Securityholders not involved in the proceeding. The holders of a majority in aggregate principal amount of the
Securities of any series at the time Outstanding affected thereby, determined in accordance with Section 8.04, may on behalf of the holders of all of the Securities of such series waive any past default in the performance of any of the
covenants contained herein or established pursuant to Section 2.01 with respect to such series and its consequences, except a default in the payment of the principal of, or premium, if any, or interest on, any of the Securities of that series
as and when the same shall become due by the terms of such Securities otherwise than by acceleration (unless such default has been cured and a sum sufficient to pay all matured installments of interest and principal and any premium has been
deposited with the Trustee (in accordance with Section 6.01(c)). Upon any such waiver, the default covered thereby shall be deemed to be cured for all purposes of this Indenture and the Company, the Trustee and the holders of the Securities of
such series shall be restored to their former positions and rights hereunder, respectively; but no such waiver shall extend to any subsequent or other default or impair any right consequent thereon. 

Section 6.07 Undertaking to Pay Costs. 
 All parties to this Indenture agree, and each holder of any Securities by such holder’s acceptance thereof shall be deemed to have agreed, that any court may in its discretion require, in any suit
for the enforcement of any right or remedy under this Indenture, or in any suit against the Trustee for any action taken or omitted by it as Trustee, the filing by any party litigant in such suit of an undertaking to pay the costs of such suit, and
that such court may in its discretion assess reasonable costs, including reasonable attorneys’ fees, against any party litigant in such 

  
 25 

 
suit, having due regard to the merits and good faith of the claims or defenses made by such party litigant; but the provisions of this Section shall not apply to any suit instituted by the
Trustee, to any suit instituted by any Securityholder, or group of Securityholders, holding more than 10% in aggregate principal amount of the Outstanding Securities of any series, or to any suit instituted by any Securityholder for the enforcement
of the payment of the principal of (or premium, if any) or interest on any Security of such series, on or after the respective due dates expressed in such Security or established pursuant to this Indenture. 

ARTICLE 7 

CONCERNING THE TRUSTEE 
 Section 7.01 Certain Duties and Responsibilities of Trustee. 

(a) The Trustee, prior to the occurrence of an Event of Default with respect to the Securities of a series and
after the curing of all Events of Default with respect to the Securities of that series that may have occurred, shall undertake to perform with respect to the Securities of such series such duties and only such duties as are specifically set forth
in this Indenture, and no implied covenants shall be read into this Indenture against the Trustee. In case an Event of Default with respect to the Securities of a series has occurred (that has not been cured or waived), the Trustee shall exercise
with respect to Securities of that series such of the rights and powers vested in it by this Indenture, and use the same degree of care and skill in their exercise, as a prudent man would exercise or use under the circumstances in the conduct of his
own affairs. 
 (b) No provision of this Indenture shall be construed to relieve the Trustee from
liability for its own negligent action, its own negligent failure to act, or its own willful misconduct, except that: 
 (i) prior to the occurrence of an Event of Default with respect to the Securities of a series and after the curing or waiving of all such Events of Default with respect to that series that may have
occurred: 
 (A) the duties and obligations of the Trustee shall with respect to the Securities of such
series be determined solely by the express provisions of this Indenture, and the Trustee shall not be liable with respect to the Securities of such series except for the performance of such duties and obligations as are specifically set forth in
this Indenture, and no implied covenants or obligations shall be read into this Indenture against the Trustee; and 
 (B) in the absence of bad faith on the part of the Trustee, the Trustee may with respect to the Securities of such series conclusively rely, as to the truth of the statements and the correctness of
the opinions expressed therein, upon any certificates or opinions furnished to the Trustee and conforming to the requirements of this Indenture; but in the case of any such certificates or opinions that by any provision hereof are specifically
required to be furnished to the Trustee, the Trustee shall be under a duty to examine the same to determine whether or not they conform to the requirements of this Indenture; 

  
 26 

 (ii) the Trustee shall not be liable for any error of judgment made
in good faith by a Responsible Officer or Responsible Officers of the Trustee, unless it shall be proved that the Trustee was negligent in ascertaining the pertinent facts; 

(iii) the Trustee shall not be liable with respect to any action taken or omitted to be taken by it in good faith
in accordance with the direction of the holders of not less than a majority in principal amount of the Securities of any series at the time Outstanding relating to the time, method and place of conducting any proceeding for any remedy available to
the Trustee, or exercising any trust or power conferred upon the Trustee under this Indenture with respect to the Securities of that series; and 
 (iv) None of the provisions contained in this Indenture shall require the Trustee to expend or risk its own funds or otherwise incur personal financial liability in the performance of any of its
duties or in the exercise of any of its rights or powers if there is reasonable ground for believing that the repayment of such funds or liability is not reasonably assured to it under the terms of this Indenture or adequate indemnity against such
risk is not reasonably assured to it. 
 Section 7.02 Certain Rights of Trustee. 

Except as otherwise provided in Section 7.01: 

(a) The Trustee may rely and shall be protected in acting or refraining from acting upon any resolution,
certificate, statement, instrument, opinion, report, notice, request, consent, order, approval, bond, security or other paper or document believed by it to be genuine and to have been signed or presented by the proper party or parties; 

(b) Any request, direction, order or demand of the Company mentioned herein shall be sufficiently evidenced by a
Board Resolution or an instrument signed in the name of the Company by any authorized officer of the Company (unless other evidence in respect thereof is specifically prescribed herein); 

(c) The Trustee may consult with counsel and the written advice of such counsel or any Opinion of Counsel shall be
full and complete authorization and protection in respect of any action taken or suffered or omitted hereunder in good faith and in reliance thereon; 
 (d) The Trustee shall be under no obligation to exercise any of the rights or powers vested in it by this Indenture at the request, order or direction of any of the Securityholders pursuant to the
provisions of this Indenture, unless such Securityholders shall have offered to the Trustee reasonable security or indemnity against the costs, expenses and liabilities that may be incurred therein or thereby; nothing contained herein shall,
however, relieve the Trustee of the obligation, upon the occurrence of an Event of Default with respect to a series of the Securities (that has not been cured or waived), to exercise with respect to Securities of that series such of the rights and
powers vested in it by this Indenture, and to use the same degree of care and skill in their exercise, as a prudent man would exercise or use under the circumstances in the conduct of his own affairs; 

  
 27 

 (e) The Trustee shall not be liable for any action taken or omitted
to be taken by it in good faith and believed by it to be authorized or within the discretion or rights or powers conferred upon it by this Indenture; 
 (f) The Trustee shall not be bound to make any investigation into the facts or matters stated in any resolution, certificate, statement, instrument, opinion, report, notice, request, consent,
order, approval, bond, security, or other papers or documents, unless requested in writing so to do by the holders of not less than a majority in principal amount of the Outstanding Securities of the particular series affected thereby (determined as
provided in Section 8.04); provided, however, that if the payment within a reasonable time to the Trustee of the costs, expenses or liabilities likely to be incurred by it in the making of such investigation is, in the opinion of the Trustee,
not reasonably assured to the Trustee by the security afforded to it by the terms of this Indenture, the Trustee may require reasonable indemnity against such costs, expenses or liabilities as a condition to so proceeding. The reasonable expense of
every such examination shall be paid by the Company or, if paid by the Trustee, shall be repaid by the Company upon demand; and 
 (g) The Trustee may execute any of the trusts or powers hereunder or perform any duties hereunder either directly or by or through agents or attorneys and the Trustee shall not be responsible for
any misconduct or negligence on the part of any agent or attorney appointed with due care by it hereunder. 
 In addition, the
Trustee shall not be deemed to have knowledge of any Default or Event of Default except (1) any Event of Default occurring pursuant to Sections 6.01(a)(1) and 6.01(a)(2) or (2) any Default or Event of Default of which the Trustee shall
have received written notification in the manner set forth in this Indenture or a Responsible Officer of the Trustee shall have obtained actual knowledge. Delivery of reports, information and documents to the Trustee under Section 5.03 is for
informational purposes only and the information and the Trustee’s receipt of the foregoing shall not constitute constructive notice of any information contained therein, or determinable from information contained therein including the
Company’s compliance with any of their covenants thereunder (as to which the Trustee is entitled to rely exclusively on an Officers’ Certificate). 
 Section 7.03 Trustee Not Responsible for Recitals or Issuance or Securities. 
 (a) The recitals contained herein and in the Securities shall be taken as the statements of the Company, and the Trustee assumes no responsibility for the correctness of the same. 

(b) The Trustee makes no representations as to the validity or sufficiency of this Indenture or of the Securities.

 (c) The Trustee shall not be accountable for the use or application by the Company of any of the
Securities or of the proceeds of such Securities, or for the use or application of any moneys paid over by the Trustee in accordance with any provision of this Indenture or established pursuant to Section 2.01, or for the use or application of
any moneys received by any paying agent other than the Trustee. 

  
 28 

 Section 7.04 May Hold Securities. 

The Trustee or any paying agent or Security Registrar, in its individual or any other capacity, may become the owner or pledgee of
Securities with the same rights it would have if it were not Trustee, paying agent or Security Registrar. 
 Section 7.05
Moneys Held in Trust. 
 Subject to the provisions of Section 11.05, all moneys received by the Trustee shall, until
used or applied as herein provided, be held in trust for the purposes for which they were received, but need not be segregated from other funds except to the extent required by law. The Trustee shall be under no liability for interest on any moneys
received by it hereunder except such as it may agree with the Company to pay thereon. 
 Section 7.06 Compensation and
Reimbursement. 
 (a) The Company covenants and agrees to pay to the Trustee, and the Trustee shall be
entitled to, such reasonable compensation (which shall not be limited by any provision of law in regard to the compensation of a trustee of an express trust) as the Company and the Trustee may from time to time agree in writing, for all services
rendered by it in the execution of the trusts hereby created and in the exercise and performance of any of the powers and duties hereunder of the Trustee, and, except as otherwise expressly provided herein, the Company will pay or reimburse the
Trustee upon its request for all reasonable expenses, disbursements and advances incurred or made by the Trustee in accordance with any of the provisions of this Indenture (including the reasonable compensation and the expenses and disbursements of
its counsel and of all Persons not regularly in its employ), except any such expense, disbursement or advance as may arise from its negligence or bad faith and except as the Company and Trustee may from time to time agree in writing. The Company
also covenants to indemnify the Trustee (and its officers, agents, directors and employees) for, and to hold it harmless against, any loss, liability or expense incurred without negligence or bad faith on the part of the Trustee and arising out of
or in connection with the acceptance or administration of this trust, including the reasonable costs and expenses of defending itself against any claim of liability in the premises. 

(b) The obligations of the Company under this Section to compensate and indemnify the Trustee and to pay or
reimburse the Trustee for reasonable expenses, disbursements and advances shall constitute additional indebtedness hereunder. Such additional indebtedness shall be secured by a lien prior to that of the Securities upon all property and funds held or
collected by the Trustee as such, except funds held in trust for the benefit of the holders of particular Securities. 

Section 7.07 Reliance on Officers’ Certificate. 
 Except as otherwise provided in Section 7.01, whenever in the administration of the provisions of this Indenture the Trustee shall deem it reasonably necessary or desirable that a matter be proved or
established prior to taking or suffering or omitting to take any action hereunder, such matter (unless other evidence in respect thereof be herein specifically prescribed) may, in the absence of negligence or bad faith on the part of the Trustee, be
deemed to be conclusively proved and established by an Officers’ Certificate delivered to the Trustee and 

  
 29 

 
such certificate, in the absence of negligence or bad faith on the part of the Trustee, shall be full warrant to the Trustee for any action taken, suffered or omitted to be taken by it under the
provisions of this Indenture upon the faith thereof. 
 Section 7.08 Disqualification; Conflicting Interests. 

If the Trustee has or shall acquire any “conflicting interest” within the meaning of Section 310(b) of the Trust Indenture
Act, the Trustee and the Company shall in all respects comply with the provisions of Section 310(b) of the Trust Indenture Act. 
 Section 7.09 Corporate Trustee Required; Eligibility. 
 There shall at all
times be a Trustee with respect to the Securities issued hereunder which shall at all times be a corporation organized and doing business under the laws of the United States of America or any state or territory thereof or of the District of
Columbia, or a corporation or other Person permitted to act as trustee by the Securities and Exchange Commission, authorized under such laws to exercise corporate trust powers, having a combined capital and surplus of at least fifty million U.S.
dollars ($50,000,000), and subject to supervision or examination by federal, state, territorial, or District of Columbia authority. 
 If such corporation or other Person publishes reports of condition at least annually, pursuant to law or to the requirements of the aforesaid supervising or examining authority, then for the purposes of
this Section, the combined capital and surplus of such corporation or other Person shall be deemed to be its combined capital and surplus as set forth in its most recent report of condition so published. The Company may not, nor may any Person
directly or indirectly controlling, controlled by, or under common control with the Company, serve as Trustee. In case at any time the Trustee shall cease to be eligible in accordance with the provisions of this Section, the Trustee shall resign
immediately in the manner and with the effect specified in Section 7.10. 
 Section 7.10 Resignation and Removal;
Appointment of Successor. 
 (a) The Trustee or any successor hereafter appointed may at any time
resign with respect to the Securities of one or more series by giving written notice thereof to the Company and by transmitting notice of resignation by mail, first class postage prepaid, to the Securityholders of such series, as their names and
addresses appear upon the Security Register. Upon receiving such notice of resignation, the Company shall promptly appoint a successor trustee with respect to Securities of such series by written instrument, in duplicate, executed by order of the
Board of Directors, one copy of which instrument shall be delivered to the resigning Trustee and one copy to the successor trustee. If no successor trustee shall have been so appointed and have accepted appointment within 30 days after the mailing
of such notice of resignation, the resigning Trustee may petition any court of competent jurisdiction for the appointment of a successor trustee with respect to Securities of such series, or any Securityholder of that series who has been a bona fide
holder of a Security or Securities for at least six months may on behalf of himself and all others similarly situated, petition any such court for the appointment of a successor trustee. Such court may thereupon after such notice, if any, as it may
deem proper and prescribe, appoint a successor trustee. 

  
 30 

 (b) In case at any time any one of the following shall occur:

 (i) the Trustee shall fail to comply with the provisions of Section 7.08 after written request
therefor by the Company or by any Securityholder who has been a bona fide holder of a Security or Securities for at least six months; or 
 (ii) the Trustee shall cease to be eligible in accordance with the provisions of Section 7.09 and shall fail to resign after written request therefor by the Company or by any such
Securityholder; or 
 (iii) the Trustee shall become incapable of acting, or shall be adjudged a bankrupt
or insolvent, or commence a voluntary bankruptcy proceeding, or a receiver of the Trustee or of its property shall be appointed or consented to, or any public officer shall take charge or control of the Trustee or of its property or affairs for the
purpose of rehabilitation, conservation or liquidation; then, in any such case, the Company may remove the Trustee with respect to all Securities and appoint a successor trustee by written instrument, in duplicate, executed by order of the Board of
Directors, one copy of which instrument shall be delivered to the Trustee so removed and one copy to the successor trustee, or any Securityholder who has been a bona fide holder of a Security or Securities for at least six months may, on behalf of
that holder and all others similarly situated, petition any court of competent jurisdiction for the removal of the Trustee and the appointment of a successor trustee. Such court may thereupon after such notice, if any, as it may deem proper and
prescribe, remove the Trustee and appoint a successor trustee. 
 (c) The holders of a majority in
aggregate principal amount of the Securities of any series at the time Outstanding may at any time remove the Trustee with respect to such series by so notifying the Trustee and the Company and may appoint a successor Trustee for such series with
the consent of the Company. 
 (d) Any resignation or removal of the Trustee and appointment of a
successor trustee with respect to the Securities of a series pursuant to any of the provisions of this Section shall become effective upon acceptance of appointment by the successor trustee as provided in Section 7.11. 

(e) Any successor trustee appointed pursuant to this Section may be appointed with respect to the Securities of one
or more series or all of such series, and at any time there shall be only one Trustee with respect to the Securities of any particular series. 
 Section 7.11 Acceptance of Appointment By Successor. 

(a) In case of the appointment hereunder of a successor trustee with respect to all Securities, every such
successor trustee so appointed shall execute, acknowledge and deliver to the Company and to the retiring Trustee an instrument accepting such appointment, and thereupon the resignation or removal of the retiring Trustee shall become effective and
such successor trustee, without any further act, deed or conveyance, shall become vested with all the rights, powers, trusts and duties of the retiring Trustee; but, on the request of the Company or the successor trustee, such retiring Trustee
shall, upon payment of its charges, execute and deliver an instrument transferring to such successor trustee all the rights, powers, and trusts of the retiring 

  
 31 

 
Trustee and shall duly assign, transfer and deliver to such successor trustee all property and money held by such retiring Trustee hereunder. 

(b) In case of the appointment hereunder of a successor trustee with respect to the Securities of one or more (but
not all) series, the Company, the retiring Trustee and each successor trustee with respect to the Securities of one or more series shall execute and deliver an indenture supplemental hereto wherein each successor trustee shall accept such
appointment and which (i) shall contain such provisions as shall be necessary or desirable to transfer and confirm to, and to vest in, each successor trustee all the rights, powers, trusts and duties of the retiring Trustee with respect to the
Securities of that or those series to which the appointment of such successor trustee relates, (ii) shall contain such provisions as shall be deemed necessary or desirable to confirm that all the rights, powers, trusts and duties of the
retiring Trustee with respect to the Securities of that or those series as to which the retiring Trustee is not retiring shall continue to be vested in the retiring Trustee, and (iii) shall add to or change any of the provisions of this
Indenture as shall be necessary to provide for or facilitate the administration of the trusts hereunder by more than one Trustee, it being understood that nothing herein or in such supplemental indenture shall constitute such Trustees co-trustees of the same trust, that each such Trustee shall be trustee of a trust or trusts hereunder separate and apart from any trust or trusts hereunder administered by any other such Trustee and that no Trustee
shall be responsible for any act or failure to act on the part of any other Trustee hereunder; and upon the execution and delivery of such supplemental indenture the resignation or removal of the retiring Trustee shall become effective to the extent
provided therein, such retiring Trustee shall with respect to the Securities of that or those series to which the appointment of such successor trustee relates have no further responsibility for the exercise of rights and powers or for the
performance of the duties and obligations vested in the Trustee under this Indenture, and each such successor trustee, without any further act, deed or conveyance, shall become vested with all the rights, powers, trusts and duties of the retiring
Trustee with respect to the Securities of that or those series to which the appointment of such successor trustee relates; but, on request of the Company or any successor trustee, such retiring Trustee shall duly assign, transfer and deliver to such
successor trustee, to the extent contemplated by such supplemental indenture, the property and money held by such retiring Trustee hereunder with respect to the Securities of that or those series to which the appointment of such successor trustee
relates. 
 (c) Upon request of any such successor trustee, the Company shall execute any and all
instruments for more fully and certainly vesting in and confirming to such successor trustee all such rights, powers and trusts referred to in paragraph (a) or (b) of this Section, as the case may be. 

(d) No successor trustee shall accept its appointment unless at the time of such acceptance such successor trustee
shall be qualified and eligible under this Article. 
 (e) Upon acceptance of appointment by a successor
trustee as provided in this Section, the Company shall transmit notice of the succession of such trustee hereunder by mail, first class postage prepaid, to the Securityholders, as their names and addresses appear upon the Security Register. If the
Company fails to transmit such notice within ten days after acceptance of appointment by the successor trustee, the successor trustee shall cause such notice to be transmitted at the expense of the Company. 

  
 32 

 Section 7.12 Merger, Conversion, Consolidation or Succession to Business. 

Any corporation into which the Trustee may be merged or converted or with which it may be consolidated, or any corporation resulting from
any merger, conversion or consolidation to which the Trustee shall be a party, or any corporation succeeding to the corporate trust business of the Trustee, including the administration of the trust created by this Indenture, shall be the successor
of the Trustee hereunder, provided that such corporation shall be qualified under the provisions of Section 7.08 and eligible under the provisions of Section 7.09, without the execution or filing of any paper or any further act on the part
of any of the parties hereto, anything herein to the contrary notwithstanding. In case any Securities shall have been authenticated, but not delivered, by the Trustee then in office, any successor by merger, conversion or consolidation to such
authenticating Trustee may adopt such authentication and deliver the Securities so authenticated with the same effect as if such successor Trustee had itself authenticated such Securities. 

Section 7.13 Preferential Collection of Claims Against the Company. 

The Trustee shall comply with Section 311(a) of the Trust Indenture Act, excluding any creditor relationship described in
Section 311(b) of the Trust Indenture Act. A Trustee who has resigned or been removed shall be subject to Section 311(a) of the Trust Indenture Act to the extent included therein. 

Section 7.14 Notice of Default 
 If any Default or any Event of Default occurs and is continuing and if such Default or Event of Default is known to a Responsible Officer of the Trustee, the Trustee shall mail to each Securityholder in
the manner and to the extent provided in Section 313(c) of the Trust Indenture Act notice of the Default or Event of Default within 45 days after it occurs, unless such Default or Event of Default has been cured; provided, however, that,
except in the case of a default in the payment of the principal of (or premium, if any) or interest on any Security, the Trustee shall be protected in withholding such notice if and so long as the board of directors, the executive committee or a
trust committee of directors and/or Responsible Officers of the Trustee in good faith determine that the withholding of such notice is in the interest of the Securityholders. 
 ARTICLE 8 
 CONCERNING THE SECURITYHOLDERS 

Section 8.01 Evidence of Action by Securityholders. 
 Whenever in this Indenture it is provided that the holders of a majority or specified percentage in aggregate principal amount of the Securities of a particular series may take any action (including the
making of any demand or request, the giving of any notice, consent or waiver or the taking of any other action), the fact that at the time of taking any such action the holders of such majority or specified percentage of that series have joined
therein may be evidenced by any instrument or any number of instruments of similar tenor executed by such holders of Securities of that series in person or by agent or proxy appointed in writing. 

  
 33 

 If the Company shall solicit from the Securityholders of any series any request, demand,
authorization, direction, notice, consent, waiver or other action, the Company may, at its option, as evidenced by an Officers’ Certificate, fix in advance a record date for such series for the determination of Securityholders entitled to give
such request, demand, authorization, direction, notice, consent, waiver or other action, but the Company shall have no obligation to do so. If such a record date is fixed, such request, demand, authorization, direction, notice, consent, waiver or
other action may be given before or after the record date, but only the Securityholders of record at the close of business on the record date shall be deemed to be Securityholders for the purposes of determining whether Securityholders of the
requisite proportion of Outstanding Securities of that series have authorized or agreed or consented to such request, demand, authorization, direction, notice, consent, waiver or other action, and for that purpose the Outstanding Securities of that
series shall be computed as of the record date; provided, however, that no such authorization, agreement or consent by such Securityholders on the record date shall be deemed effective unless it shall become effective pursuant to the provisions of
this Indenture not later than six months after the record date. 
 Section 8.02 Proof of Execution by Securityholders.

 Subject to the provisions of Section 7.01, proof of the execution of any instrument by a Securityholder (such proof
will not require notarization) or his agent or proxy and proof of the holding by any Person of any of the Securities shall be sufficient if made in the following manner: 

(a) The fact and date of the execution by any such Person of any instrument may be proved in any reasonable manner
acceptable to the Trustee. 
 (b) The ownership of Securities shall be proved by the Security Register of
such Securities or by a certificate of the Security Registrar thereof. 
 The Trustee may require such additional proof of any matter referred
to in this Section as it shall deem necessary. 
 Section 8.03 Who May be Deemed Owners. 

Prior to the due presentment for registration of transfer of any Security, the Company, the Trustee, any paying agent and any Security
Registrar may deem and treat the Person in whose name such Security shall be registered upon the books of the Company as the absolute owner of such Security (whether or not such Security shall be overdue and notwithstanding any notice of ownership
or writing thereon made by anyone other than the Security Registrar) for the purpose of receiving payment of or on account of the principal of, premium, if any, and (subject to Section 2.03) interest on such Security and for all other purposes;
and neither the Company nor the Trustee nor any paying agent nor any Security Registrar shall be affected by any notice to the contrary. 
 Section 8.04 Certain Securities Owned by Company Disregarded. 
 In
determining whether the holders of the requisite aggregate principal amount of Securities of a particular series have concurred in any direction, consent or waiver under this 

  
 34 

 
Indenture, the Securities of that series that are owned by the Company or any other obligor on the Securities of that series or by any Person directly or indirectly controlling or controlled by
or under common control with the Company or any other obligor on the Securities of that series shall be disregarded and deemed not to be Outstanding for the purpose of any such determination, except that for the purpose of determining whether the
Trustee shall be protected in relying on any such direction, consent or waiver, only Securities of such series that the Trustee actually knows are so owned shall be so disregarded. The Securities so owned that have been pledged in good faith may be
regarded as Outstanding for the purposes of this Section, if the pledgee shall establish to the satisfaction of the Trustee the pledgee’s right so to act with respect to such Securities and that the pledgee is not a Person directly or
indirectly controlling or controlled by or under direct or indirect common control with the Company or any such other obligor. In case of a dispute as to such right, any decision by the Trustee taken upon the advice of counsel shall be full
protection to the Trustee. 
 Section 8.05 Actions Binding on Future Securityholders. 

At any time prior to (but not after) the evidencing to the Trustee, as provided in Section 8.01, of the taking of any action by the
holders of the majority or percentage in aggregate principal amount of the Securities of a particular series specified in this Indenture in connection with such action, any holder of a Security of that series that is shown by the evidence to be
included in the Securities the holders of which have consented to such action may, by filing written notice with the Trustee, and upon proof of holding as provided in Section 8.02, revoke such action so far as concerns such Security. Except as
aforesaid any such action taken by the holder of any Security shall be conclusive and binding upon such holder and upon all future holders and owners of such Security, and of any Security issued in exchange therefor, on registration of transfer
thereof or in place thereof, irrespective of whether or not any notation in regard thereto is made upon such Security. Any action taken by the holders of the majority or percentage in aggregate principal amount of the Securities of a particular
series specified in this Indenture in connection with such action shall be conclusively binding upon the Company, the Trustee and the holders of all the Securities of that series. 

ARTICLE 9 

SUPPLEMENTAL INDENTURES 
 Section 9.01 Supplemental Indentures Without the Consent of Securityholders. 
 In addition to any supplemental indenture otherwise authorized by this Indenture, the Company and the Trustee may from time to time and at any time enter into an indenture or indentures supplemental
hereto (which shall conform to the provisions of the Trust Indenture Act as then in effect), without the consent of the Securityholders, for one or more of the following purposes: 

(a) to cure any ambiguity, defect, or inconsistency herein or in the Securities of any series; 

(b) to comply with Article Ten; 

  
 35 

 (c) to provide for uncertificated Securities in addition to or in
place of certificated Securities; 
 (d) to add to the covenants, restrictions, conditions or provisions
relating to the Company for the benefit of the holders of all or any series of Securities (and if such covenants, restrictions, conditions or provisions are to be for the benefit of less than all series of Securities, stating that such covenants,
restrictions, conditions or provisions are expressly being included solely for the benefit of such series), to make the occurrence, or the occurrence and the continuance, of a default in any such additional covenants, restrictions, conditions or
provisions an Event of Default, or to surrender any right or power herein conferred upon the Company; 

(e) to add to, delete from, or revise the conditions, limitations, and restrictions on the authorized amount,
terms, or purposes of issue, authentication, and delivery of Securities, as herein set forth; 
 (f) to
make any change that does not adversely affect the rights of any Securityholder in any material respect; 

(g) to provide for the issuance of and establish the form and terms and conditions of the Securities of any series
as provided in Section 2.01, to establish the form of any certifications required to be furnished pursuant to the terms of this Indenture or any series of Securities, or to add to the rights of the holders of any series of Securities;

 (h) to evidence and provide for the acceptance of appointment hereunder by a successor trustee; or

 (i) to comply with any requirements of the Securities and Exchange Commission or any successor in
connection with the qualification of this Indenture under the Trust Indenture Act. 
 The Trustee is hereby authorized to join
with the Company in the execution of any such supplemental indenture, and to make any further appropriate agreements and stipulations that may be therein contained, but the Trustee shall not be obligated to enter into any such supplemental indenture
that affects the Trustee’s own rights, duties or immunities under this Indenture or otherwise. 
 Any supplemental
indenture authorized by the provisions of this Section may be executed by the Company and the Trustee without the consent of the holders of any of the Securities at the time Outstanding, notwithstanding any of the provisions of Section 9.02.

 Section 9.02 Supplemental Indentures With Consent of Securityholders. 

With the consent (evidenced as provided in Section 8.01) of the holders of not less than a majority in aggregate principal amount of
the Securities of each series affected by such supplemental indenture or indentures at the time Outstanding, the Company, when authorized by a Board Resolution, and the Trustee may from time to time and at any time enter into an indenture or
indentures supplemental hereto (which shall conform to the provisions of the Trust Indenture Act as then in effect) for the purpose of adding any provisions to or changing in any 

  
 36 

 
manner or eliminating any of the provisions of this Indenture or of any supplemental indenture or of modifying in any manner not covered by Section 9.01 the rights of the holders of the
Securities of such series under this Indenture; provided, however, that no such supplemental indenture shall, without the consent of the holders of each Security then Outstanding and affected thereby, (a) extend the fixed maturity of any
Securities of any series, or reduce the principal amount thereof, or reduce the rate or extend the time of payment of interest thereon, or reduce any premium payable upon the redemption thereof or (b) reduce the aforesaid percentage of
Securities, the holders of which are required to consent to any such supplemental indenture. 
 It shall not be necessary for
the consent of the Securityholders of any series affected thereby under this Section to approve the particular form of any proposed supplemental indenture, but it shall be sufficient if such consent shall approve the substance thereof. 

Section 9.03 Effect of Supplemental Indentures. 
 Upon the execution of any supplemental indenture pursuant to the provisions of this Article or of Section 10.01, this Indenture shall, with respect to such series, be and be deemed to be modified and
amended in accordance therewith and the respective rights, limitations of rights, obligations, duties and immunities under this Indenture of the Trustee, the Company and the holders of Securities of the series affected thereby shall thereafter be
determined, exercised and enforced hereunder subject in all respects to such modifications and amendments, and all the terms and conditions of any such supplemental indenture shall be and be deemed to be part of the terms and conditions of this
Indenture for any and all purposes. 
 Section 9.04 Securities Affected by Supplemental Indentures. 

Securities of any series affected by a supplemental indenture, authenticated and delivered after the execution of such supplemental
indenture pursuant to the provisions of this Article or of Section 10.01, may bear a notation in form approved by the Company, provided such form meets the requirements of any securities exchange upon which such series may be listed, as to any
matter provided for in such supplemental indenture. If the Company shall so determine, new Securities of that series so modified as to conform, in the opinion of the Board of Directors, to any modification of this Indenture contained in any such
supplemental indenture may be prepared by the Company, authenticated by the Trustee and delivered in exchange for the Securities of that series then Outstanding. 
 Section 9.05 Execution of Supplemental Indentures. 
 Upon the request of
the Company, accompanied by its Board Resolutions authorizing the execution of any such supplemental indenture, and upon the filing with the Trustee of evidence of the consent of Securityholders required to consent thereto as aforesaid, the Trustee
shall join with the Company in the execution of such supplemental indenture unless such supplemental indenture affects the Trustee’s own rights, duties or immunities under this Indenture or otherwise, in which case the Trustee may in its
discretion but shall not be obligated to enter into such supplemental indenture. The Trustee, subject to the provisions of Section 7.01, may receive an Officers’ Certificate or an Opinion of Counsel as conclusive evidence that any
supplemental indenture executed pursuant to this Article is authorized or permitted by, and conforms to, the 

  
 37 

 
terms of this Article and that it is proper for the Trustee under the provisions of this Article to join in the execution thereof; provided, however, that such Officers’ Certificate or
Opinion of Counsel need not be provided in connection with the execution of a supplemental indenture that establishes the terms of a series of Securities pursuant to Section 2.01 hereof. 

Promptly after the execution by the Company and the Trustee of any supplemental indenture pursuant to the provisions of this Section, the
Trustee shall transmit by mail, first class postage prepaid, a notice, setting forth in general terms the substance of such supplemental indenture, to the Securityholders of all series affected thereby as their names and addresses appear upon the
Security Register. Any failure of the Trustee to mail such notice, or any defect therein, shall not, however, in any way impair or affect the validity of any such supplemental indenture. 

ARTICLE 10 

SUCCESSOR ENTITY 
 Section 10.01 Company May Consolidate, Etc. 
 Except as provided pursuant
to Section 2.01 pursuant to a Board Resolution, and set forth in an Officers’ Certificate, or established in one or more indentures supplemental to this Indenture, nothing contained in this Indenture shall prevent any consolidation or
merger of the Company with or into any other Person (whether or not affiliated with the Company) or successive consolidations or mergers in which the Company or its successor or successors shall be a party or parties, or shall prevent any sale,
conveyance, transfer or other disposition of the property of the Company or its successor or successors as an entirety, or substantially as an entirety, to any other corporation (whether or not affiliated with the Company or its successor or
successors) authorized to acquire and operate the same; provided, however, (a) the Company hereby covenants and agrees that, upon any such consolidation or merger (in each case, if the Company is not the survivor of such transaction), sale,
conveyance, transfer or other disposition, the due and punctual payment of the principal of (premium, if any) and interest on all of the Securities of all series in accordance with the terms of each series, according to their tenor, and the due and
punctual performance and observance of all the covenants and conditions of this Indenture with respect to each series or established with respect to such series pursuant to Section 2.01 to be kept or performed by the Company shall be expressly
assumed, by supplemental indenture (which shall conform to the provisions of the Trust Indenture Act, as then in effect) reasonably satisfactory in form to the Trustee executed and delivered to the Trustee by the entity formed by such consolidation,
or into which the Company shall have been merged, or by the entity which shall have acquired such property and (b) in the event that the Securities of any series then Outstanding are convertible into or exchangeable for shares of common stock
or other securities of the Company, such entity shall, by such supplemental indenture, make provision so that the Securityholders of Securities of that series shall thereafter be entitled to receive upon conversion or exchange of such Securities the
number of securities or property to which a holder of the number of shares of common stock or other securities of the Company deliverable upon conversion or exchange of those Securities would have been entitled had such conversion or exchange
occurred immediately prior to such consolidation, merger, sale, conveyance, transfer or other disposition. 

  
 38 

 Section 10.02 Successor Entity Substituted. 

(a) In case of any such consolidation, merger, sale, conveyance, transfer or other disposition and upon the
assumption by the successor entity by supplemental indenture, executed and delivered to the Trustee and satisfactory in form to the Trustee, of the obligations set forth under Section 10.01 on all of the Securities of all series Outstanding,
such successor entity shall succeed to and be substituted for the Company with the same effect as if it had been named as the Company herein, and thereupon the predecessor corporation shall be relieved of all obligations and covenants under this
Indenture and the Securities. 
 (b) In case of any such consolidation, merger, sale, conveyance, transfer
or other disposition, such changes in phraseology and form (but not in substance) may be made in the Securities thereafter to be issued as may be appropriate. 
 (c) Nothing contained in this Article shall require any action by the Company in the case of a consolidation or merger of any Person into the Company where the Company is the survivor of such
transaction, or the acquisition by the Company, by purchase or otherwise, of all or any part of the property of any other Person (whether or not affiliated with the Company). 
 Section 10.03 Evidence of Consolidation, Etc. to Trustee. 
 The Trustee,
subject to the provisions of Section 7.01, may receive an Officers’ Certificate or an Opinion of Counsel as conclusive evidence that any such consolidation, merger, sale, conveyance, transfer or other disposition, and any such assumption,
comply with the provisions of this Article. 
 ARTICLE 11 

SATISFACTION AND DISCHARGE 
 Section 11.01 Satisfaction and Discharge of Indenture. 
 If at any time:
(a) the Company shall have delivered to the Trustee for cancellation all Securities of a series theretofore authenticated and not delivered to the Trustee for cancellation (other than any Securities that shall have been destroyed, lost or
stolen and that shall have been replaced or paid as provided in Section 2.07 and Securities for whose payment money or Governmental Obligations have theretofore been deposited in trust or segregated and held in trust by the Company and
thereupon repaid to the Company or discharged from such trust, as provided in Section 11.05); or (b) all such Securities of a particular series not theretofore delivered to the Trustee for cancellation shall have become due and payable, or
are by their terms to become due and payable within one year or are to be called for redemption within one year under arrangements satisfactory to the Trustee for the giving of notice of redemption, and the Company shall deposit or cause to be
deposited with the Trustee as trust funds the entire amount in moneys or Governmental Obligations or a combination thereof, sufficient in the opinion of a nationally recognized firm of independent public accountants expressed in a written
certification thereof delivered to the Trustee, to pay at maturity or upon redemption all Securities of that series not theretofore delivered to the Trustee for cancellation, including principal (and premium, if any) and interest due or to become
due to such date of maturity or date fixed for redemption, as the case may be, and if the Company shall also pay or cause to be paid all other sums payable 

  
 39 

 
hereunder with respect to such series by the Company then this Indenture shall thereupon cease to be of further effect with respect to such series except for the provisions of Sections 2.03,
2.05, 2.07, 4.01, 4.02, 4.03 and 7.10, that shall survive until the date of maturity or redemption date, as the case may be, and Sections 7.06 and 11.05, that shall survive to such date and thereafter, and the Trustee, on demand of the Company and
at the cost and expense of the Company shall execute proper instruments acknowledging satisfaction of and discharging this Indenture with respect to such series. 
 Section 11.02 Discharge of Obligations. 
 If at any time all such
Securities of a particular series not heretofore delivered to the Trustee for cancellation or that have not become due and payable as described in Section 11.01 shall have been paid by the Company by depositing irrevocably with the Trustee as
trust funds moneys or an amount of Governmental Obligations sufficient to pay at maturity or upon redemption all such Securities of that series not theretofore delivered to the Trustee for cancellation, including principal (and premium, if any) and
interest due or to become due to such date of maturity or date fixed for redemption, as the case may be, and if the Company shall also pay or cause to be paid all other sums payable hereunder by the Company with respect to such series, then after
the date such moneys or Governmental Obligations, as the case may be, are deposited with the Trustee the obligations of the Company under this Indenture with respect to such series shall cease to be of further effect except for the provisions of
Sections 2.03, 2.05, 2.07, 4,01, 4.02, 4,03, 7.06, 7.10 and 11.05 hereof that shall survive until such Securities shall mature and be paid. 
 Thereafter, Sections 7.06 and 11.05 shall survive. 
 Section 11.03 Deposited
Moneys to be Held in Trust. 
 All moneys or Governmental Obligations deposited with the Trustee pursuant to Sections 11.01
or 11.02 shall be held in trust and shall be available for payment as due, either directly or through any paying agent (including the Company acting as its own paying agent), to the holders of the particular series of Securities for the payment or
redemption of which such moneys or Governmental Obligations have been deposited with the Trustee. 
 Section 11.04 Payment of
Moneys Held by Paying Agents. 
 In connection with the satisfaction and discharge of this Indenture all moneys or
Governmental Obligations then held by any paying agent under the provisions of this Indenture shall, upon demand of the Company, be paid to the Trustee and thereupon such paying agent shall be released from all further liability with respect to such
moneys or Governmental Obligations. 
 Section 11.05 Repayment to Company. 

Any moneys or Governmental Obligations deposited with any paying agent or the Trustee, or then held by the Company, in trust for payment
of principal of or premium, if any, or interest on the Securities of a particular series that are not applied but remain unclaimed by the holders of such Securities for at least two years after the date upon which the principal of (and

  
 40 

 
premium, if any) or interest on such Securities shall have respectively become due and payable, or such other shorter period set forth in applicable escheat or abandoned or unclaimed property
law, shall be repaid to the Company on May 31 of each year or upon the Company’s request or (if then held by the Company) shall be discharged from such trust; and thereupon the paying agent and the Trustee shall be released from all
further liability with respect to such moneys or Governmental Obligations, and the holder of any of the Securities entitled to receive such payment shall thereafter, as a general creditor, look only to the Company for the payment thereof.

 ARTICLE 12 
 IMMUNITY OF INCORPORATORS, STOCKHOLDERS, OFFICERS AND DIRECTORS 

Section 12.01 No Recourse. 
 No recourse under or upon any obligation, covenant or agreement of this Indenture, or of any Security, or for any claim based thereon or otherwise in respect thereof, shall be had against any
incorporator, stockholder, officer or director, past, present or future as such, of the Company or of any predecessor or successor corporation, either directly or through the Company or any such predecessor or successor corporation, whether by
virtue of any constitution, statute or rule of law, or by the enforcement of any assessment or penalty or otherwise; it being expressly understood that this Indenture and the obligations issued hereunder are solely corporate obligations, and that no
such personal liability whatever shall attach to, or is or shall be incurred by, the incorporators, stockholders, officers or directors as such, of the Company or of any predecessor or successor corporation, or any of them, because of the creation
of the indebtedness hereby authorized, or under or by reason of the obligations, covenants or agreements contained in this Indenture or in any of the Securities or implied therefrom; and that any and all such personal liability of every name and
nature, either at common law or in equity or by constitution or statute, of, and any and all such rights and claims against, every such incorporator, stockholder, officer or director as such, because of the creation of the indebtedness hereby
authorized, or under or by reason of the obligations, covenants or agreements contained in this Indenture or in any of the Securities or implied therefrom, are hereby expressly waived and released as a condition of, and as a consideration for, the
execution of this Indenture and the issuance of such Securities. 
 ARTICLE 13 

MISCELLANEOUS PROVISIONS 
 Section 13.01 Effect on Successors and Assigns. 
 All the covenants,
stipulations, promises and agreements in this Indenture made by or on behalf of the Company shall bind its successors and assigns, whether so expressed or not. 
 Section 13.02 Actions by Successor. 
 Any act or proceeding by any
provision of this Indenture authorized or required to be done or performed by any board, committee or officer of the Company shall and may be done 

  
 41 

 
and performed with like force and effect by the corresponding board, committee or officer of any corporation that shall at the time be the lawful successor of the Company. 

Section 13.03 Surrender of Company Powers. 
 The Company by instrument in writing executed by authority of its Board of Directors and delivered to the Trustee may surrender any of the powers reserved to the Company, and thereupon such power so
surrendered shall terminate both as to the Company and as to any successor corporation. 
 Section 13.04 Notices.

 Except as otherwise expressly provided herein, any notice, request or demand that by any provision of this Indenture is
required or permitted to be given, made or served by the Trustee or by the holders of Securities or by any other Person pursuant to this Indenture to or on the Company may be given or served by being deposited in first class mail, postage prepaid,
addressed (until another address is filed in writing by the Company with the Trustee), as follows: Inovio Pharmaceuticals, Inc., 11494 Sorrento Valley Road, San Diego, California, 92121, Attn: Chief Financial Officer. Any notice, election, request
or demand by the Company or any Securityholder or by any other Person pursuant to this Indenture to or upon the Trustee shall be deemed to have been sufficiently given or made, for all purposes, if given or made in writing at the Corporate Trust
Office of the Trustee. 
 Section 13.05 Governing Law. 

This Indenture and each Security shall be deemed to be a contract made under the internal laws of the State of New York, and for all
purposes shall be construed in accordance with the laws of said State, except to the extent that the Trust Indenture Act is applicable. 
 Section 13.06 Treatment of Securities as Debt. 
 It is intended that the
Securities will be treated as indebtedness and not as equity for federal income tax purposes. The provisions of this Indenture shall be interpreted to further this intention. 
 Section 13.07 Certificates and Opinions as to Conditions Precedent. 
 (a) Upon any application or demand by the Company to the Trustee to take any action under any of the provisions of this Indenture, the Company shall furnish to the Trustee an Officers’
Certificate stating that all conditions precedent provided for in this Indenture (other than the certificate to be delivered pursuant to Section 13.12) relating to the proposed action have been complied with and an Opinion of Counsel stating
that in the opinion of such counsel all such conditions precedent have been complied with, except that in the case of any such application or demand as to which the furnishing of such documents is specifically required by any provision of this
Indenture relating to such particular application or demand, no additional certificate or opinion need be furnished. 

  
 42 

 (b) Each certificate or opinion provided for in this Indenture and
delivered to the Trustee with respect to compliance with a condition or covenant in this Indenture shall include (i) a statement that the Person making such certificate or opinion has read such covenant or condition; (ii) a brief statement
as to the nature and scope of the examination or investigation upon which the statements or opinions contained in such certificate or opinion are based; (iii) a statement that, in the opinion of such Person, he has made such examination or
investigation as is reasonably necessary to enable him to express an informed opinion as to whether or not such covenant or condition has been complied with; and (iv) a statement as to whether or not, in the opinion of such Person, such
condition or covenant has been complied with. 
 Section 13.08 Payments on Business Days. 

Except as provided pursuant to Section 2.01 pursuant to a Board Resolution, and set forth in an Officers’ Certificate, or
established in one or more indentures supplemental to this Indenture, in any case where the date of maturity of interest or principal of any Security or the date of redemption of any Security shall not be a Business Day, then payment of interest or
principal (and premium, if any) may be made on the next succeeding Business Day with the same force and effect as if made on the nominal date of maturity or redemption, and no interest shall accrue for the period after such nominal date. 

Section 13.09 Conflict with Trust Indenture Act. 
 If and to the extent that any provision of this Indenture limits, qualifies or conflicts with the duties imposed by Sections 310 to 317, inclusive, of the Trust Indenture Act, such imposed duties shall
control. 
 Section 13.10 Counterparts. 
 This Indenture may be executed in any number of counterparts, each of which shall be an original, but such counterparts shall together constitute but one and the same instrument. 

Section 13.11 Separability. 
 In case any one or more of the provisions contained in this Indenture or in the Securities of any series shall for any reason be held to be invalid, illegal or unenforceable in any respect, such
invalidity, illegality or unenforceability shall not affect any other provisions of this Indenture or of such Securities, but this Indenture and such Securities shall be construed as if such invalid or illegal or unenforceable provision had never
been contained herein or therein. 
 Section 13.12 Compliance Certificates. 

The Company shall deliver to the Trustee, within 120 days after the end of each fiscal year during which any Securities of any series
were outstanding, an officer’s certificate stating whether or not the signers know of any Default or Event of Default that occurred during such fiscal year. Such certificate shall contain a certification from the principal executive officer,
principal financial officer or principal accounting officer of the Company that a review has been conducted of the activities of the Company and the Company’s performance under this Indenture and that the Company has complied with all
conditions and covenants under this Indenture. For 

  
 43 

 
purposes of this Section 13.12, such compliance shall be determined without regard to any period of grace or requirement of notice provided under this Indenture. If the officer of the
Company signing such certificate has knowledge of such a Default or Event of Default, the certificate shall describe any such Default or Event of Default and its status. 

  
 44 

 IN WITNESS WHEREOF, the
parties hereto have caused this Indenture to be duly executed all as of the day and year first above written. 
  

			
	INOVIO PHARMACEUTICALS, INC.
		
	By:	 	 
	Name:	 	 
	Title:	 	 
	
	[TRUSTEE], as Trustee
		
	By:	 	 
	Name:	 	 
	Title:	 	 

 CROSS-REFERENCE TABLE (1) 

 

			
	Section of Trust Indenture Act of 1939, as Amended	  	Section of Indenture
	 310(a)
	  	7.09
	 310(b)
	  	7.08
		  	7.10
	 310(c)
	  	Inapplicable
	 311(a)
	  	7.13
	 311(b)
	  	7.13
	 311(c)
	  	Inapplicable
	 312(a)
	  	5.01
		  	5.02(a)
	 312(b)
	  	5.02(c)
	 312(c)
	  	5.02(c)
	 313(a)
	  	5.04(a)
	 313(b)
	  	5.04(b)
	 313(c)
	  	5.04(a)
		  	5.04(b)
	 313(d)
	  	5.04(c)
	 314(a)
	  	5.03
		  	13.12
	 314(b)
	  	Inapplicable
	 314(c)
	  	13.07(a)
	 314(d)
	  	Inapplicable
	 314(e)
	  	13.07(b)
	 314(f)
	  	Inapplicable
	 315(a)
	  	7.01(a)
		  	7.01(b)
	 315(b)
	  	7.14
	 315(c)
	  	7.01
	 315(d)
	  	7.01(b)
	 315(e)
	  	6.07
	 316(a)
	  	6.06
		  	8.04
	 316(b)
	  	6.04
	 316(c)
	  	8.01
	 317(a)
	  	6.02
	 317(b)
	  	4.03
	 318(a)
	  	13.09

  

	(1)	This Cross-Reference Table does not constitute part of the Indenture and shall not have any bearing on the interpretation of any of its terms or provisions.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00245-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00245-of-00352.parquet"}]]